
==== Front
Chin Med
Chin Med
Chinese Medicine
1749-8546
BioMed Central London

39252074
995
10.1186/s13020-024-00995-x
Review
Application of omics technologies in studies on antitumor effects of Traditional Chinese Medicine
Tan Peng 12
Wei Xuejiao 12
Huang Huiming 12
Wang Fei 12
Wang Zhuguo 12
Xie Jinxin 12
Wang Longyan 12
Liu Dongxiao 12
http://orcid.org/0000-0003-4849-3353
Hu Zhongdong zdhu@bucm.edu.cn

2
1 https://ror.org/05damtm70 grid.24695.3c 0000 0001 1431 9176 School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029 China
2 https://ror.org/05damtm70 grid.24695.3c 0000 0001 1431 9176 Modern Research Center for Traditional Chinese Medicine, Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029 China
9 9 2024
9 9 2024
2024
19 12328 6 2024
2 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Traditional Chinese medicine (TCM) is considered to be one of the most comprehensive and influential form of traditional medicine. It plays an important role in clinical treatment and adjuvant therapy for cancer. However, the complex composition of TCM presents challenges to the comprehensive and systematic understanding of its antitumor mechanisms, which hinders further development of TCM with antitumor effects. Omics technologies can immensely help in elucidating the mechanism of action of drugs. They utilize high-throughput sequencing and detection techniques to provide deeper insights into biological systems, revealing the intricate mechanisms through which TCM combats tumors. Multi-omics approaches can be used to elucidate the interrelationships among different omics layers by integrating data from various omics disciplines. By analyzing a large amount of data, these approaches further unravel the complex network of mechanisms underlying the antitumor effects of TCM and explain the mutual regulations across different molecular levels. In this study, we presented a comprehensive overview of the recent progress in single-omics and multi-omics research focused on elucidating the mechanisms underlying the antitumor effects of TCM. We discussed the significance of omics technologies in advancing research on the antitumor properties of TCM and also provided novel research perspectives and methodologies for further advancing this research field.

Keywords

Traditional Chinese Medicine
Antitumor
Omics technologies
Mechanism investigation
Beijing Natural Science FoundationJ230034 Hu Zhongdong http://dx.doi.org/10.13039/501100001809 National Natural Science Foundation of China 82074072 81873044 Hu Zhongdong http://dx.doi.org/10.13039/501100012226 Fundamental Research Funds for the Central Universities 2023-JYB-JBQN-051 Hu Zhongdong Talent Cultivation Project of Beijing University of Chinese MedicineJZPY202206 Hu Zhongdong issue-copyright-statement© International Society for Chinese Medicine and BioMed Central Ltd. 2024
==== Body
pmcIntroduction

Tumors are characterized by abnormal proliferation of normal cells in the body, caused by a combination of various internal and external factors; malignant tumors are commonly known as cancers [1]. According to global cancer statistics, in 2020, approximately 19.3 million cases of cancer were newly diagnosed globally, and nearly 10 million deaths were recorded [2]. The current existing methods to combat tumors primarily involve the use of radiotherapy, chemotherapy, or surgical resection. Although radiation therapy is effective in treating various solid tumors including breast cancer, lung cancer, and colorectal cancer, it can also cause harm to normal tissues, leading to various adverse reactions (e.g., radiation pneumonitis, enteritis, lymphopenia) and increasing the risk of tumor recurrence and metastasis [3, 4]. The long-term repeated administration of chemotherapeutic agents leads to the development of acquired resistance (e.g., overexpression of P-glycoprotein and multidrug resistance-associated protein genes) and significant toxicity, thereby greatly limiting their clinical utility [5]. The above reasons often lead to treatment failure or poor prognosis for cancer patients.

Traditional Chinese medicine (TCM) is an indispensable part of public health in China and is gradually gaining acceptance in Western countries [6]. In TCM theory, tumors are considered to be “pathogenic factors” or “evil.” Research has indicated that numerous traditional Chinese herbs, compounds, and their active components exhibit antitumor activities. For example, the main component of Astragalus membranaceus, i.e., astragalus polysaccharide, can exert antitumor effects through multiple pathways, such as cell cycle regulation, enhancement of immune function, and reversal of drug resistance [7, 8]. Xihuang pill is a well-known classic anti-cancer formula used in clinical practice. It shows favorable effects on various malignant tumors and is commonly used as an adjuvant therapy to improve patient prognosis [9–11]. Traditional Chinese herbs and formulations exhibit intricate chemical compositions. This complexity often leads to synergistic effects of multiple active ingredients interacting with multiple molecular targets ultimately exerting antitumor effects through multiple pathways (as shown in Fig. 1). Therefore, traditional studies that focus only on a single target or pathway cannot comprehensively elucidate the complex antitumor mechanisms of TCM [12]. This significantly hinders the further development of anti-tumor Chinese herbal medicine and fails to benefit clinical patients.Fig. 1 Traditional Chinese Medicine (TCM) exerts anti-tumor effects through multiple pathways and targets. TCM has the characteristics of "multi-component, multi-target, multi-pathway". It plays an anti-tumor role by inhibiting tumor cell proliferation, promoting tumor cell apoptosis, improving immune response, reversing drug resistance and other ways

Omics technologies refer to an integrated approach that combines multiple high-throughput technologies and data analysis methods to measure and analyze various molecular levels within an organism, revealing interactions and functional associations among different molecules, including genomics, proteomics, transcriptomics, and other related techniques [13]. With the continuous advancement in high-throughput sequencing, liquid chromatography-mass spectrometry (LC–MS), gas chromatography-mass spectrometry (GC–MS), and other technologies, omics studies are generating extremely rich datasets, which provide new methods for investigating the mechanism of action of TCM and contribute to the modernization of TCM [14]. Currently, a significant amount of research on TCM for anticancer purposes has greatly benefited from omics technologies, particularly transcriptomics and proteomics. By comparing changes in overall transcript levels or protein levels in tumor cells or tissue samples and conducting enrichment analysis, researchers can identify potential pathways or targets through which TCM exerts its anticancer effects, thereby providing guidance for future studies. Additionally, muti-omics technologies can be utilized at various levels to elucidate the mechanisms of action of TCM in anticancer treatment; for instance, the combination of metagenomics and metabolomics can effectively illustrate how TCM indirectly exerts its anticancer effects through the gut microbiota. These approaches align with the holistic concept of TCM, which emphasizes a comprehensive understanding and treatment of diseases. The omics technologies will facilitate the elucidation of the underlying mechanisms behind the significant anti-tumor effects of TCM, thereby advancing its further clinical applications, particularly for Chinese medicine formulas.

In this review, we provided a comprehensive overview of the applications of omics technologies in antitumor research in the field of TCM, including transcriptomics, proteomics, metabolomics, microbiomics, single-cell omics, and integrated multi-omics approaches. We emphasize their significance and limitations in this field to enhance their utilization.

Omics technologies

In 1958, Crick proposed the “Central Dogma” after discovering the double-helical structure of deoxyribonucleic acid (DNA). He detailed the process of genetic information transcription from DNA to RNA and its translation into proteins in living organisms [15]. Genomics, transcriptomics, proteomics, and metabolomics represent the four levels of genetic information corresponding to replication, transcription, translation, and regulation, respectively, in the Central Dogma. However, traditional omics studies are based on mixed cell populations, which makes it challenging to obtain differential information and spatial positioning information of different types of cells [16]. Single-cell omics technologies were innovated as a solution to address this issue. These advancements enabled thorough analysis on a large scale across various dimensions such as genomics, transcriptomics, proteomics, and other levels in each cell in the sample [17]. Omics technologies can be used to accurately predict tumor biomarkers [18], novel therapeutic targets [19], and tumor heterogeneity [20]. They can also be used to elucidate the mechanisms of antitumor drugs [21]. The commonly applied omics technologies in current studies on antitumor mechanisms of TCM include transcriptomics, proteomics, metabolomics, microbiomics, and single-cell omics. The main techniques and applications of these techniques are summarized in Fig. 2.Fig. 2 The application of omics technologies in anti-tumor research of traditional Chinese Medicine (TCM).The intervention of TCM in cancers leads to changes in mRNA, protein and other biological levels. These changes can be detected by RNA-seq, SILAC, 16S rRNA-seq and other histological techniques and help to reveal the complex anti-tumor network of TCM

Transcriptomics

Transcriptomics research methodologies encompass DNA microarray, employing hybridization techniques, and various high-throughput sequencing techniques. Commonly used DNA microarray platforms are further classified into complementary deoxyribonucleic acid (cDNA) microarrays and oligonucleotide microarrays, based on the probe molecules used [22]. The advent of next generation sequencing (NGS) has significantly advanced transcriptomics in the post-genomic era by overcoming challenges related to throughput and cost, which were prevalent prior to the technological advancements in sequencing methodologies [23]. RNA sequencing (RNA-seq), in which the entire cDNA of a sample is sequenced using NGS, is widely performed in the field of transcriptomic research following TCM intervention. Compared to other methods, such as those involving microarrays, RNA-seq offers high sensitivity and accuracy [24]. The commonly used representative NGC platforms include Roche 454, Illumina, BGI Genomics, etc. [25, 26]. To address the limitations of short read lengths, template switching during polymerase chain reaction (PCR) amplification, and difficulties in analyzing complex repetitive sequences associated with NGS, third-generation sequencing technologies, such as single-molecule real-time sequencing (SMRT-seq) and nanopore single-molecule sequencing, have emerged as promising alternatives [27].

Proteomics

Due to the significant advancements in protein/peptide enrichment techniques, isotope labeling methods, and mass spectrometry technology, substantial progress has been made in qualitative and quantitative proteomics based on mass spectrometry [28]. Quantitative proteomics is the core of proteomic techniques and one of the most common approaches used to study the antitumor effects of TCM. Commonly used quantitative techniques include label-free quantification proteomics [29], data independent acquisition/sequential window acquisition of all theoretical spectra (DIA/SWATH) proteomics [30, 31] and isotope labeling-based tandem mass tags/isobaric tag for relative absolute quantitation (TMT/iTRAQ) and stable-isotope labelling by amino acids in cell culture (SILAC) proteomics [32–34]. The major difference between the two proteomic strategies lies in whether isotopic labeling is applied to proteins or peptides. In label-free quantification techniques, proteins are directly extracted, enzymatically digested, and then, analyzed using LC–MS. Relative quantification is performed based on the peak area or capture frequency of peptides. This method is cheap and avoids potential errors introduced by labeling and is suitable for analyzing differential protein expression in large-scale samples [29]. Unlike label-free quantification, TMT/iTRAQ involves isotopic labeling of peptides. The labeled samples are simultaneously analyzed by LC–MS/MS, and the quantification between samples is performed based on the relative intensities of the mass spectrometry peaks that correspond to differentially expressed proteins. This method yields a larger amount of data with higher quantitative accuracy compared to the data obtained via label-free quantification and can be used for comparing differential protein expression between samples from different interventions or time points [34]. DIA/SWATH is a data-independent acquisition (DIA) mode of scanning that differs from the conventional data-dependent acquisition (DDA) mode. In DIA/SWATH, secondary fragmentation of peptide precursors is performed, which allows for the relative/absolute quantification of proteins based on the resulting signals [35]. This approach provides richer and more accurate information compared to that provided by traditional DDA methods [31].

Metabolomics

Metabolomics, a nascent discipline within the realm of omics, embodies the subsequent facet of systems biology. It is the omics method closest to the biological phenotype [36]. Based on the application of metabolomics, it can be divided into untargeted and targeted metabolomics [37]. The former methodology is centered on the comparative assessment of diverse small-molecule metabolites within samples, enabling the detection of distinct metabolites that vary across various groups. In contrast, the latter approach emphasizes the precise measurement of individual metabolites or a specific category, such as lipids, which can be used to validate differences in metabolic expression. Due to the complex physicochemical properties of metabolites, such as polarity and stability, the effectiveness and accuracy of metabolomics heavily rely on the selection of analytical platforms. The most popular analysis platforms for metabolomics include LC–MS, GC–MS, and nuclear magnetic resonance spectroscopy (NMR) [38]. Although NMR results are highly reproducible and the equipment is easy to operate, it can detect fewer metabolites than other analytical methods [38]. As no single separation method can cover the entire metabolome, LC–MS is commonly used for analyzing semi-polar metabolites, whereas GC–MS is preferred for analyzing volatile organic compounds and lipids [39]. Additionally, for untargeted metabolomics studies, multiple platforms are commonly used for concurrent detection to achieve a higher success rate by maximizing the coverage of metabolites [38].

Microbiomics

Research on the gut microbiome has evolved significantly as a result of advancements in sequencing and mass spectrometry technologies, moving away from conventional culture methods to embrace the utilization of omics techniques [40]. Microbiomics is the study of all microorganisms in a specific environment. The 16S ribosomal RNA gene sequencing (16S rRNA-seq) and metagenomics techniques are most commonly used to study gut microbiota. The conventional approaches for 16S rRNA-seq and metagenomics rely on NGS. The 16S rRNA-seq technique targets specific hypervariable regions (e.g., V4 or V3–V4 regions) of the rDNA in microbial populations [41]. Metagenomics involves random fragmentation and PCR amplification of the total DNA extracted from microbial samples for sequencing [41]. As NGS-based 16S rRNA sequencing has short read lengths, it is unable to sequence the complete 16S rRNA gene. Hence, this technique can identify fewer bacteria at the species level than metagenomics [42]. However, these problems were resolved after the introduction of third-generation sequencing technologies, such as PacBio and Oxford Nanopore, which can be used to sequence the complete 16S rRNA gene [43]. Besides elucidating the composition of the gut microbiota, metagenomics can be employed to investigate microbial genes and their functional attributes through bioinformatics analysis. However, 16S rRNA sequencing and metagenomics cannot directly characterize the functional activities of microorganisms. Therefore, following the advancements in mass spectrometry technology, new areas of microbiome research, such as metaproteomics and metabolomics, have emerged [44, 45].

Single-cell omics

Traditional omics technologies only provide information on dominant cell populations, often ignoring the information on cell populations with low abundance but high heterogeneity. Single-cell omics technologies can effectively address this issue by allowing the study of individual cells at a high resolution [46]. Single-cell omics methods have advanced considerably in recent years, and new technologies are being developed continuously. Among these methods, single-cell RNA sequencing (scRNA-seq) has received much attention. The key challenge in scRNA-seq lies in capturing individual cells, which was addressed with the development of droplet-based and microwell-based techniques and other technologies such as droplet-based single-cell RNA sequencing (Drop-seq), indexed droplet single-cell RNA sequencing (in Drop), 10 × Gem Code, and BD Rhapsody [47]. Single-cell cDNA amplification techniques, such as 3ʹ-end tagging, switching mechanism at the 5ʹ end of RNA template sequencing (Smart-seq), cellular indexing of transcriptomes and epitopes by sequencing (CEL-seq), etc., can also be used to amplify RNA from single cells [48]. With the advancement of single-cell omics, it is now possible to simultaneously detect multiple omics levels from individual cells. For example, techniques such as genome and transcriptome sequencing (G&T-seq) and TARGET-seq allow concurrent profiling of the whole transcriptome and genome of single cells [49, 50]. Techniques such as methylome and transcriptome sequencing from single-cells (scM&T-seq) and droplet-based single-nucleus chromatin accessibility and mRNA expression sequencing (SNARE-seq) have facilitated joint analysis of the transcriptome and the epigenome [51, 52]. Additionally, using the cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) and RNA end-associated purification sequencing (REAP-seq) techniques, researchers have combined single-cell transcriptomics with proteomics [53, 54].

Application of omics in the study of TCM for antitumor purposes

Transcriptomics

In transcription, genetic information flows from DNA to RNA. The study of the overall transcriptional landscape and changes in specific cell or tissue samples under certain conditions is known as transcriptomics. Transcriptomics can provide insights into the global transcriptional alterations in tumor cells or tissues before and after treatment with TCM. It can be used to understand the mechanisms underlying the antitumor effects of TCM (see Table 1 for details). Table 1 Application of transcriptomics in studies on antitumor mechanisms of TCM

TCM type	Research object	Cancer type	Main technology	Main anti-tumor mechanism	References	
Traditional Chinese medicine formulas	Xianlinglianxiafang	Breast cancer	RNA-seq	↓ The growth and metastasis of TNBC by ↑ the PPARγ/AMPK signaling pathway	[55]	
Xihuang pill	Lung cancer	RNA-seq	Through multiple pathways including tumor necrosis factor, estrogen, cGMP, etc	[56]	
Cinobufacini injection	Breast cancer	RNA-seq	Apoptosis and cell cycle arrest ↑ through the Pin1-TAZ pathway	[57]	
Biejiajian pill	Liver cancer	RNA-seq	↓ PDGFRβ signaling pathway, VEGF-A and HGF	[21]	
Yishen

Qutong granule

	Lung cancer	RNA-seq	↓ Oxidative stress-related protein HMOX1 expression	[58]	
Yangyinwenyang formula	Lung cancer	RNA-seq	↑ DC maturation and T cell proliferation and differentiation through the MAPK and NF-kB signaling pathways	[59]	
Traditional Chinese herbs/monomers	Trametes robiniophila Murr	Breast cancer	cDNA microarray	↑ G0/G1 cell cycle arrest, ↓ RAD51,and interference with DNA repair to sensitization of radiotherapy	[60]	
Aloe	Colorectal cancer	RNA-seq	↑ Wnt/β-catenin pathway and ↓ Notch pathway	[61]	
Coptidis rhizome	Breast cancer	cDNA microarray	↑ IFN-b and exhibiting anti-tumor effects through autocrine pathways	[62]	
4-Methoxydalbergione (from Dalbergia odorifera)	Astroglioma	RNA-seq	↑ G2/M cell cycle arrest and cellular apoptosis through cell ↓ cycle-related genes (such as RRM2, BUB1, CDK1, etc.)	[63]	
Evodiamine (from Evodia rutaecarpa)	Esophageal squamous cell carcinoma	RNA-seq	↑ Mitotic cell cycle arrest through the CUL4A/p53/p21 axis and intrinsic-dependent apoptosis via Noxa	[64]	
Polydatin (from Polygonum cuspidatum)	Liver cancer	RNA-seq	↓ Expression of five genes involved in regulating the formation of the spindle midzone	[65]	
N-trans-Feruloyloctopamine (from garlic skin)	Liver cancer	RNA-Seq	↑ Apoptosis in liver cancer cells by modulating the proteins BBC3, DDIT3, CDKN1A, and NOXA	[66]	
Periplocin (from Cortex periplocae)	Pancreatic cancer	RNA-seq	↑ Autophagy by modulating the AMPK/mTOR pathway	[67]	
Cinobufagin (from Bufonis Venenum)	Human acute myeloid leukaemia	RNA-seq	↓ c-myc-related genes	[68]	
Neobractatin (from Garcinia bracteata)	Cervical cancer	RNA-seq	↑ G1/S phase and G2/M phase arrest through ↓ E2F1 and ↑ GADD45α	[69]	
Timosaponin AIII (from Anemarrhenae Rhizoma)	Tumor angiogenesis	RNA-seq	↓ Tumor angiogenesis through the VEGF/PI3K/Akt/MAPK signaling pathway	[70]	
Solamargine (from Solanum nigrum L.)	Multiple myeloma	RNA-seq	The anti-tumor effect is exerted by ↑ autophagy pathway	[71]	
Shikonin (from Lithospermum erythrorhizon)	Breast cancer	RNA-seq	↑ DUSP1, DUSP2 and exerting anti-breast cancer effect via the JNK and p38-MAPK pathways	[72]	
N-Butylidenephthalide (from Radix Angelica Sinensis)	Gastric cancer	RNA-seq	↑ REDD1, ↓ mTOR signaling pathway and intramitochondrial signaling pathways	[73]	
“↑” represents increase, promote or up-regulate, while “↓” represents inhibit, suppress, decrease or down-regulate. The same goes for the tables in the back

Traditional Chinese medicine formulas

Chen et al. [21] performed RNA-seq to revealed that the Biejiajian pill might inhibit the development of liver cancer by downregulating the platelet-derived growth factor receptor-β (PDGFRβ) signaling pathway, as determined by RT-PCR and western blot analyses. The downstream proteins of the PDGFRβ signaling pathway, including phosphoinositide 3-kinase (PI3K), AKT, and GSK3β, were also detected, which indicated that they are involved in the mechanisms underlying the preventive effects of Biejiajian pill on the progression of liver cancer [21]. Zhao et al. [59] formulated the optimized prescription named Yangyinwenyang (YYWY) by refining kangfujin, demonstrating its favorable efficacy in combating lung cancer. The transcriptomics findings further revealed that the therapeutic properties of this compound are intricately linked to immune-mediated pathways, notably involving cytokine-cytokine receptor interaction as well as chemokine/NOD-like receptor/IL-17/NF-kB signaling pathways and finally proved the anti-tumor effect by promoting the proliferation and differentiation of mature DC-activated T cells [59].

Traditional Chinese herbs and monomers

Ding et al. [60] used the HTA 2.0 gene chip to investigate the radiosensitizing mechanism of Huai’er aqueous extract. The researchers found that Huai’er aqueous extract downregulated the expression of genes related to DNA repair, cell cycle, and cell division in MCF-7 cells. Further research found that the extract increased the sensitivity of breast cancer cells to radiation therapy by arresting the cell cycle and down-regulating radiation-sensitive mutant 51 (RAD51) [60]. One of the main chemical components of Jiangxiang is 4-methoxydalbergione (4-MDO). Transcriptome sequencing of U87 glioma cells treated with 4-MDO (0 µM or 5.0 µM for 12 h) showed that 158 genes were upregulated and 204 genes were downregulated [63]. Several genes associated with the cell cycle, including ribonucleotide reductase M2 (RRM2), minichromosome maintenance complex component 7 (MCM7), Budding Uninhibited by Benzimidazoles 1 Homolog Beta (BUB1B), Cyclin A2 (CCNA2), and CDK inhibitor 1 (CDK1), exhibited notable alterations. These findings suggested that 4MDO might be an effective therapeutic agent for treating glioma, considering and acts by blocking G2/M [63].

Proteomics

Proteomics is used to investigate the entire protein composition and interactions within cells or tissues under specific conditions [74]. It not only provides qualitative and quantitative data on the overall protein content but also enables qualitative and quantitative analyses of post-translational modifications of proteins, including glycosylation, phosphorylation, ubiquitination, etc. [75]. Therefore, proteomics can be used as a complementary technology for studying the mechanisms of antitumor effects of TCM (details in Table 2). Table 2 Application of proteomics in studies on antitumor mechanisms of TCM

TCM type	Research object	Cancer type	Main technology	Main anti-tumor mechanism	References	
Traditional Chinese medicine formulas	Pien Tze Huang	Liver cancer	Protein chip	Modulating the secretion of inflammation-related cytokines, tumor growth pathways, and ↑ G2/M phase arrest	[76]	
Aidi injection optimal formula	Liver cancer/Colorectal cancer	TMT-based quantitative proteomics	Chen medicine can antagonize the activity of UPS lead by Jun medicine	[77]	
Traditional Chinese herbs/monomers	Camellia nitidissima Chi	Colon Cancer	Label-free quantitative proteomics	Regulating iron death pathway-associated proteins such as GPX4 and HMOX1	[78]	
Salvia chinensia Benth	Esophageal cancer	TMT-based quantitative proteomics	↑ P-AMPK, P-ULK1, LC3 II/I and AMPK/ULK1 pathway	[79]	
Antrodia Cinnamomea	Liver cancer	2D-DIGE/MALDI-TOF MS proteomics	Regulating pathways related to protein folding, cellular cytoskeleton, and oxidation–reduction	[80]	
Dendrobium nobile	Lung cancer and liver cancer	SILAC quantitative proteomics	↑ ROS, ER stress and UPR and leading to autophagy and apoptosis	[81]	
Lindera obtusiloba Blume	Tumor angiogenesis	Protein chip	↑ Nibrin/NBS, ↓ Plk-1 and Cyclin E	[82]	
Celastrus Orbiculatus Vine	liver cancer	TMT / iTRAQ quantitative proteomics	↓ EphA2, tumor growth and angiogenesis	[83]	
Astragalus polysaccharide (from Astragali Radix)	Lung cancer	Label-free quantitative proteomics	Regulating the tumor microenvironment through the TLR4/MyD88/NF-κB signaling pathway	[84]	
Corilagin (from Phyllanthus niruri L)	Ovarian cancer	Protein chip and iTRAQ quantitative proteomics	↑ Apoptosis-related protein expression, ↓ CD44, STAT3 and glycolysis	[85]	
Triptolide (from Tripterygium wilfordii)	Lung cancer	iTRAQ quantitative proteomics	↑ MTA2 and EIF4A3, ↓ PHB, CDH1 and AIFM1, and regulating PARP1/AIF and Akt signaling pathways	[86]	
Celastrol (from Tripterygium wilfordii)	Cervical cancer	TMT-based quantitative proteomics	Confirming that GSTO1 and PDI are the targets	[87]	
Plectranthoic acid (from Ficus microcarpa)	Prostate cancer	Label-free quantitative proteomics	Through signaling pathways such as granulin A, endoplasmic reticulum stress, and mTOR	[88]	
Curcumin (from Curcuma longa)	Chronic myelogenous leukemia	SWATH quantitative proteomics	Through the miR-22/IPO7/HIF-1α axis	[89]	
SANT (monomer combination)	Breast cancer	Protein chip	↓ Blood vessel formation-related proteins (such as HB-EGF and IGFBP-9)	[90]	

Traditional Chinese medicine formulas

Fan et al. [76] treated liver cancer xenograft Balb/c mice with administering Pien Tze Huang (0.234 g/kg) for 14 days and analyzed the phosphorylated proteins and signaling pathways in tumor tissues by conducting ingenuity pathway analysis (IPA). They identified 95 differentially phosphorylated proteins, which were enriched in multiple pathways related to inflammation, cancer growth, and cell cycle [76]. This study proved that Pien Tze Huang may exert its antitumor effects by regulating the secretion of inflammation-related cytokines and tumor growth pathways and inducing cell cycle arrest at the G2/M phase [76].

Traditional Chinese herbs and monomers

Chen et al. [78] used 4D-Label free proteomics analysis and found that 157 proteins were upregulated and 206 proteins were downregulated in HCT116 cells after treatment with Jinhua tea. The results of the gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) analyses indicated that these proteins were mainly associated with processes such as cell proliferation, apoptosis, and the cell cycle, and they were closely related to iron death pathways [78]. Li et al. [91] found that atractylenolide I (ATI) effectively inhibited the occurrence and development of colorectal tumors. Using proteomics techniques, they identified d-dopachrome tautomerase (D-DT) as a potential target for ATI in suppressing adenoma formation and confirmed that ATI can increase the expression of autophagy-related 7 (Atg7), Beclin, and microtubule-associated proteins 1A/1B light chain 3B (LC3B) in a dose-dependent manner. The findings showed that the inhibitory effects of ATI on the formation of colon cancer are associated with the activation of autophagy and the downregulation of D-DT [91].

Metabolomics

Metabolomics can be used to characterize and quantify small-molecule metabolites in specific samples by combining separation techniques with high-resolution analysis techniques. Metabolomics has been extensively utilized to elucidate the mechanisms underlying the antitumor effects of TCM (details in Table 3). Table 3 Application of metabolomics in studies on antitumor mechanisms of TCM

TCM type	Research object	Cancer type	Main technology	Main anti-tumor mechanism	References	
Traditional Chinese hedicine formulas	Si Jun Zi Tang	Lung cancer	Q-TOF LC/MS	Regulating the lever of 2-oxoglutarate, tauroursodeoxycholic acid, oxidized glutathione, etc.	[92]	
Si-Ni-San	breast cancer	LC/MS	Inhibiting breast cancer growth by suppressing estradiol level via modulating FXR/EST signaling	[93]	
Shuihonghuazi formula	Liver cancer	HPLC/ESI-TOF–MS	Regulating the activity of PEMT and hemolytic phospholipase d, ↑ intake and utilization of linoleic acid and oleic acid and ↑ abnormal bile acid metabolism	[12]	
Xiaojin pills	Breast cancer	LC/MS	The ethanol extract, ↑ cholesterol sulfate, amino caproic acid glycocholic acid and ↓ l-glutamine	[94]	
Modified Si Jun Zi Tang	Gastric cancer	UHPLC-Q-TOF/MS	↓ LDH, GS, PCYT2 and regulating glycolysis, lipid metabolism, etc	[95]	
Traditional Chinese herbs/monomers	Glycyrrhiza glabra	Nasopharyngeal carcinoma	GC/MS	↓ Amino acids and lipid metabolites and enriching in multiple amino acid and lipid metabolic pathways	[96]	
Frankincense -myrrh	Multiple myeloma	UPLC/Q-TOF–MS	Regulating the JAK/STAT signaling pathway and suppressing cellular metabolism	[97]	
Spica Schizonepetae	Lung cancer	UPLC-QTOF-MS	Regulating metabolism of glycerophospholipids, purines, histidine, and arachidonic acid, etc	[98]	
BFI, CFI (from Chansu)	Liver cancer	UHPLC-MS/MS	Exerting synergistic effects through the metabolic pathways of phenylalanine, α-linolenic acid, and amino acids	[99]	
BFI, CFI (from Chansu)	Liver cancer	LC − MS/MS	Exerting synergistic effects through methionine metabolism	[100]	
Magnoline

(from Phellodendri amurensis cortex)

	Prostate cancer	UHPLC-HDMS/MS	The significant impact of 12 metabolites (such as phenylalanine, tyrosine, etc.)	[101]	

Traditional Chinese medicine formulas

Zhang et al. [93] conducted a study which demonstrated the ability of Si-Ni-San to inhibit the growth and metastasis of breast cancer by activating estrogen sulfotransferase (EST) to promote the sulfation of estradiol. Furthermore, the study identified changes in 78 metabolites, including taurochenodeoxycholic acid and taurocholic acid, in the livers of mice before and after drug administration through metabolomics, with a primary focus on the bile acid metabolism pathway [93]. The research has conclusively demonstrated that Si-Ni-San can activate the expression of farnesoid X receptor (FXR) through bile acids, thereby inhibiting the transcription of estrogen sulfotransferase (EST) mediated by hepatocyte nuclear factor 4a (HNF4a) in liver cells, ultimately resulting in elevated estradiol levels [93]. Liu et al. [94] found that the ethanol extract of the xiaojin pill has stronger anti-breast cancer effects than the water extract on a BALB/c nude mouse model of breast cancer metastasis and on cells in vitro. The results of metabolomics analysis showed that cholesterol sulfate and 6-aminohexanoic acid levels were significantly higher in the ethanol extract group, whereas l-glutamine and glycocholic acid levels were significantly lower and the differential metabolites were enriched in pathways related to glycerophospholipid metabolism, alanine metabolism, and aspartate metabolism [94]. The findings of that study provided a theoretical basis for changing the administration route of xiaojin Pill from “water-based” to “alcohol-based”.

Traditional Chinese herbs and monomers

Wang et al. [98] demonstrated the anti-tumor effects of Spica Schizonepeta on Lewis lung carcinoma mice. Using QTOF-MS/MS-based metabolomics technology, they showed that treatment with Spica Schizonepetae extract resulted in changes in the levels of 23 endogenous metabolites (including uridine-3-ribonucleotide, indole-3-acetic acid, adenine, etc.) in A549 cells, which were enriched in 16 pathways, including glycerophospholipid metabolism, purine metabolism, histidine metabolism, etc. [98]. Zhang et al. [100] demonstrated that the combined use of bufalin (BFL) and cinobufagin (CBF) has a stronger anti-cancer effect in vitro. Then LC–MS metabolomics technology was used to confirm that the synergistic enhancement mechanism of BFL and CBF was associated with the methionine metabolism pathway, revealing the potential of BFL and CBF combination for clinical treatment of liver cancer.

Microbiomics

The gut microbiota, consisting of beneficial and pathogenic bacteria, represents the largest microbial community within the human body. Several studies have shown that the dysregulation of the gut microbiota composition and function is closely associated with the occurrence and development of cancer [102]. TCM can exert indirect anti-tumor effects by improving the gut microbiota, which are usually accompanied by changes in metabolic functions and cancer immune activation. Therefore, when elucidating the mechanism underlying the antitumor activity of TCM through gut microbiota, microbiomics and metabolomics are frequently employed in conjunction with each other. The combined application of these two omics is shown in Table 4. Table 4 Application of microbiomics in studies on antitumor mechanisms of TCM

TCM type	Research object	Cancer type	Main technology	Main anti-tumor mechanism	References	
Traditional Chinese medicine formulas	Sini decoction	Colorectal cancer	16S rRNA-seq	Altering the composition of gut microbiota and modulating intestinal immunity	[103]	
Yi-Yi-Fu-Zi-Bai-Jiang-San	Colorectal cancer	16S rRNA-seq	Reshaping the gut microbiota, such as Bacteroides fragilis and Lachnospiraceae, while suppressing Treg cells	[104]	
Wenzi Jiedu recipe	Colorectal cancer	16S rRNA-seq	↑ Osci llibacter and Bacteroides_acidifacien, and CD8+ T cells	[105]	
Jiawei Xiaoyao san	Liver cancer	16S rRNA-seq and Metabolomics	↑ Beneficial bacteria, ↓ harmful bacteria, regulating primary bile acid biosynthesis and phenylalanine metabolism	[106]	
Gegen Qinlian decoction	Colorectal cancer	16S rRNA-seq and Metabolomics	↑ s__Bacteroides_acidifaciens, regulating glycerophospholipid and sphingolipid metabolism and activating the immune system	[107]	
Traditional Chinese herbs/monomers	Curcumin (from Curcuma Longa)	Colorectal cancer	16S rRNA-seq	↓ Bacteroidaceae, Ruminococcaceae, Firmicutes, and ↑ Lactobacillaceae Bifidobacteriaceae	[108]	
glycyrrhiza polysaccharide (from Glycyrrhiza uralensis Fisch.)	Colorectal cancer	16S rRNA-seq	GCP can significantly alter the gut microbiota to exert anti-tumor effects, which was further validated by FMT experiments	[109]	
Panax Ginseng	Liver cancer	16S rRNA-seq and Metabolomics	Modulating gut microbiota composition and its close association with bile acids, unsaturated fatty acids	[110]	
Astragalus Mongholicus

Bunge-Curcuma Aromatica Salisb

	Colorectal cancer	16S rRNA-seq and Metabolomics	Enhancing gut microbiota diversity and increasing the levels of short-chain fatty acids such as propionic acid and butyric acid	[111]	
Tetrastigma hemsleyanum Diels et Gilg	Colorectal cancer	16S rRNA-seq and Metabolomics	↑ Beneficial bacteria, ↓harmful bacteria, and restoring abnormal metabolites in the feces	[112]	
Ginsenoside Rg3 (from Panax Ginseng)	Liver cancer	16S rRNA-seq and Metabolomics	↑ Bacteroidetes and Verrucomicrobia, ↓ Firmicutes and Measuring indole-3-propionic acid and urea	[113]	
Ginseng polysaccharides (from Panax Ginseng)	Lung cancer	16S rRNA-seq and Metabolomics	↑ Parabacteroides distasonis and Bacteroides vulgatus, ↑ butyric acid, ↓ l-tryptophan and Kyn/Trp to enhance the effect of αPD-1	[114]	

Traditional Chinese medicine formulas

Lv et al. [107] conducted in vivo experiments and found that the anti-PD-1 immune therapeutic efficacy was significantly enhanced by Ge-Gen-Qin-Lian decoction (300 mg/kg). Through 16S rRNA sequencing, Akkermansia (s__Bacteroides_acidifaciens and s__uncultured_organism_g__norank_f__Bacteroidales_S24-7_group) were significantly enriched in the combination treatment group, whereas plasma metabolomics analysis showed substantial changes in sphingolipid and glycerophospholipid metabolism [107]. The combined treatment group also exhibited higher levels of interferon gamma (IFN-γ) and interleukin-2 (IL-2), lower levels of programmed death 1 (PD-1), and greater infiltration of CD8+ T cells in the tumor tissues of mice [107]. Liver stagnation and spleen deficiency are the main syndromes of TCM in the diagnosis of liver cancer. Li et al. used 16S rRNA sequencing and plasma metabolomics to investigate the impact of modified Iiawei xiaoyaowan (JWXY) on the gut microbiota composition in a rat model of liver cancer with liver depression and spleen deficiency syndrome [106]. The intervention by JWXY resulted in an increase in the abundance of Firmicutes and a decrease in the abundance of Bacteroidetes [106]. They conducted a metabolic pathway analysis and found changes in 11 pathways, including primary bile acid biosynthesis and phenylalanine metabolism, compared to the state of those pathways in the model group [106].

Traditional Chinese herbs and monomers

Astragalus mongholicus Bunge-Curcuma aromatica Salisb extract (ACE) is a commonly used drug in the clinical treatment of tumors. Gu et al. conducted 16S rRNA sequencing and targeted metabolomics analysis on fecal samples from colon cancer-bearing mice treated with ACE extract and found that ACE effectively inhibited the growth of harmful bacteria like Streptococcus and Enterococcus, while enhancing the presence of beneficial bacteria such as Lactobacillus and Prevotella [111]. ACE increased the levels of short-chain fatty acids such as propionic acid and butyric acid, and the anti-colorectal cancer effect of ACE was ultimately attributed to the inhibition of the stromal cell-derived factor-1/C-X-C motif chemokine receptor 4 (SDF-1/CXCR4) signaling pathway [111]. Ginseng polysaccharides (GPs) exert antitumor activity by modulating the immune system. Huang et al. [114] conducted a fecal microbiota transplantation (FMT) experiment and found that the combination treatment of GPs with an anti-programmed death-1 antibody (αPD-1) monoclonal antibodies (mAbs) led to the reshaping of the intestinal microbiota in PD-1 non-responsive mice by upregulating the levels of Bacteroides dorei and Bacteroides vulgatus. In addition, GPs increased the level of butyric acid and decreased the l-kynurenine/tryptophan (Kyn/Trp) ratio [114]. These changes converted mice that were non-responsive to immunotherapy into responsive ones, thus enhancing the antitumor response to αPD-1 monoclonal antibodies [114].

Single-cell omics

Single-cell omics diverge from conventional omics as they enable the precise acquisition of molecular information, such as information on genes, mRNA, and proteins, at the level of individual cells. This approach can be used to study tumor cell heterogeneity [115], the tumor microenvironment (TME) [116], tumor resistance [117], and other related areas. Due to the significant progress in single-cell RNA sequencing (scRNA-seq) technology, it has become an important methodology in elucidating the complex antitumor molecular mechanisms of TCM. Wu et al. used a combined strategy of traditional RNA-seq and scRNA-seq to examine the impact of Compound Kushen Injection (CKI) in conjunction with paclitaxel (PTX) on the tumor microenvironment (TME) of triple-negative breast cancer (TNBC) [118]. By sequencing 174,434 cells, the researchers found that the combined treatment of CKI and paclitaxel PTX significantly enhanced immune responses and facilitated T-cell activation, resulting in a higher proportion of cytotoxic T cells and NK cells in tumor tissue [118]. The discovery underscored the ability of CKI to boost the efficacy of chemotherapy by activating immune responses [118]. WZ35, a derivative of curcumin, can rapidly induce ROS production and inhibit the metastasis of gastric cancer (GC) cells. Chen et al. [119] employed a metabolomics methodology to demonstrated that WZ35 can regulate amino acid metabolism and deplete GSH through multiple pathways. To further investigate the mechanism, the researchers analyzed single-cell sequencing data from 33,031 cells of 128 gastric cancer patients. They found a strong correlation between the expression of yes-associated protein (YAP) and AXL receptor tyrosine kinase (AXL) genes and EMT, as well as, amino acid metabolism [119]. Further experiments showed that WZ35 effectively downregulated the levels of AXL and YAP proteins and upregulated the expression of the metastasis-associated protein N-cadherin [119]. Compound Andrographis Indica Tablet is an oral arsenic agent widely used in the treatment of acute promyelocytic leukemia (APL). To explore the scientific knowledge of As2O3-indigo formula compatibility, Zhang et al. chose arsenic trioxide (As2O3: A), tanshinone IIA (T) and indirubin (I) as representative active compounds ofrealgar, indigo naturalis, and Salvia miltiorrhiza and treated leukemic mice with A, AT, AI, and ATI, followed by single-cell transcript sequencing analysis of bone and bone marrow stromal cells from each group [120]. The combination of ATI was found to have the strongest therapeutic effect in the mouse APL model and to be most sensitive to Lepr-MSCs, OLC, and BMEC cell populations compared to the A, AT, or AI groups [120]. Based on the scRNA-seq data, ATI can regulate the gene expression related to osteogenic differentiation, adipogenic differentiation, and endothelial cell migration of bone marrow mesenchymal stromal cells, thereby improving the expression of normal hematopoiesis-related genes and adverse prognosis in leukemia mice Lepr-MSCs, OLCs, and BMECs [120].

Application of multi-omics in studies of TCM for antitumor purposes

With the continuous advancements in single-omics technologies, the amount of data obtained has increased significantly. However, single-omics approaches are unable to fully characterize biological features as biological processes are complex and integrated. Therefore, further integration and analysis of multi-omics data, with mutual validation at multiple molecular levels, can more systematically elucidate the overall regulatory mechanisms of TCM in antitumor effects (details in Table 5). Table 5 Application of multi-omics in studies on antitumor mechanisms of TCM

TCM type	Research object	Cancer type	Omics type	Main anti-tumor mechanism	References	
Traditional Chinese medicine formulas	Weining granule	Gastric cancer	Epigenomics, transcriptomics, and proteomics	Relevant targets: SOD2, MMP1, SRXN1, NOTCH1, MAPK14

Relevant pathways; PI3K-Akt, MAPK

	[121]	
Yiqi Sanjie formula	Colorectal cancer	Proteomics and metabolomics	Changing 57 proteins and 37 metabolites which are enriched in inflammation, sphingolipid metabolism, and cholesterol metabolism-related pathways	[122]	
Xian-Lian-Jie-Du decoction	Colorectal cancer	Transcriptomics and proteomics	↑ Mfsd2a, Ccdc85c and ↓B cells in the tumor microenvironment	[123]	
Canmei formula	Colorectal cancer	Transcriptomicsand proteomics	Regulating LHPP through the PI3K/Akt signaling pathway	[124]	
Traditional Chinese herbs/monomers	Marsdenia tenacissima (Roxb.) Moon	Liver cancer	Transcriptomics and metabolomics	Targeting P53, JAK-1, and HIF1α to exert anti-hepatocellular carcinoma activity	[125]	
Inonotus hispidus	Liver cancer	Transcriptomics, and proteomics	Five key genes: Lilrb4a, Nrp1, Gzma, Gstt1, and Pdk4	[126]	
Shikonin (from Lithospermum erythrorhizon)	Hematological malignancies	Transcriptomics, and proteomics	↓ IGF1R-Akt-mTOR pathway by ↓ AKT phosphorylation and IGF1R kinase activity	[127]	
Cepharanthine (from Stephania cepharantha Hayata)	Liver cancer	Transcriptomics and metabolomics	Altering 168 genes which enriched in metabolic pathways (such as multiple amino acid levels)	[128]	
Cinobufagin (from Chansu)	Liver cancer	Transcriptomics and metabolomics	Interfering with metabolic reprogramming, including lipid, amino acid, carbohydrate, and nucleotide metabolism	[129]	
Bufalin (from Chansu)	Liver cancer	Transcriptomics and metabolomics	Regulating the ATP1A1/CA1 axis and downregulating the SREBP-2/FASN/ACLY pathway	[130]	

Traditional Chinese medicine formulas

Wening granules (WNG) is a well-known formulation that is clinically used for treating gastric cancer. Liang et al. [121] integrated reduced representation bisulfite sequencing (RRBS), TMT-based quantitative proteomics, and RNA-seq to construct a comprehensive molecular landscape of SGC-7901 cells treated with WNG. They identified 1249 differentially expressed genes (DEGs), 191 differentially abundant proteins (DAPs), and 8293 differentially methylated regions [121]. Through comprehensive analysis of the RNA and protein data, 95 genes were identified to exhibit significant changes at both levels, and further protein–protein interaction (PPI) network analysis confirmed the top eight candidate genes, including recombinant human superoxide dismutase (SOD2), heme oxygenase 1 (HMOX1), and matrix metalloproteinase-1 (MMP1) [121]. Similarly, by integrating RNA and DNA-related data, eight hub genes were selected, such as RNA polymerase II subunit F (POLR2F), peptidylprolyl isomerase like 4 (PPIL4), and retinoblastoma-binding protein 7 (RBBP7) [121]. By integrating the final data, SOD2, sulfiredoxin 1 (SRXN1), neurogenic locus notch homolog protein 1 (NOTCH1), and mitogen-activated protein kinase 14 (MAPK14) were predicted to be the target genes for the anti-gastric cancer effects of WNG [121].

Traditional Chinese herbs and monomers

Li et al. [125] studied Marsdenia tenacissima extracts (MTE) using LC–MS and identified three compounds (TI, TG, and TH) that contributed the most to the circulating components of mouse serum after they were administered. Then, researchers identified differential genes and metabolites by transcriptomics and metabolomics, respectively [125]. The five common targets, including tyrosine-protein kinase (JAK-1), PI3K, and hypoxia-inducible factor (HIF-1), were selected by combining the predictions of targets through bloodstream components, omics-related targets, and liver cancer-related targets [125]. In addition, molecular docking analysis showed that TI, TG, and TH could target p53, HIF1α, and JAK1, respectively, and collectively exert anti-hepatocellular carcinoma effects [125]. These findings highlighted the characteristics of TCM, where multiple components act on multiple targets synergistically. Fan Feng et al. [128] conducted in vivo and in vitro experiments to demonstrate that Triptolide has significant anti-hepatocellular carcinoma effects. Then, the results of the RNA-seq analysis showed that treatment with Triptolide affected the expression of 166 genes (53 upregulated and 113 downregulated) in HCCLM3 cells; these genes enriched pathways related to necrosis and metabolism and metabolomics analysis showed that metabolites such as 4-aminobutyric acid and l-5-oxoproline were significantly reduced [128]. These results suggested that Triptolide exerts antitumor effects by modulating various amino acid metabolic pathways [128].

Application of omics-network pharmacology in studies of TCM for antitumor purposes

Network pharmacology (NP) is a scientific discipline based on systems biology that integrates biological networks to reveal the interactions among drugs, genes, targets, and diseases [131]. The intricate composition and multi-target nature of TCM align with the comprehensive, systematic, and integrative features of NP. Therefore, NP is an important tool for investigating the mechanism of action of TCM [132]. However, there are concerns about the reliability of acquiring data on the components of traditional Chinese herbs and their target genes from databases using traditional network pharmacology. The integration of omics and NP not only increases the authenticity of the NP data but also compensates for the limitations in the correlation between herbal components and target genes in omics studies. Hence, this strategy is extensively used, as shown in Table 6. Table 6 Application of omics-network pharmacology in studies on antitumor mechanisms of TCM

TCM type	Research object	Cancer type	Omics type	Main anti-tumour mechanism	References	
Traditional Chinese medicine formulas	BL 02	Lung cancer	NP and transcriptomics	The anti-tumor activity may be directly attributed to the interaction of mangiferin and 5-methylcoumarin-4-cellobioside with Rap1	[133]	
Chang qing formula	Colorectal cancer	NP and transcriptomics	↓ IL-17a, MMP9, and NF-κB/IL-6/STAT3 signaling pathway	[134]	
Xihuang pill	Breast cancer	NP and proteomics	Modulating the PI3K-AKT signaling pathway	[135]	
Weijing decoction	Lung cancer	NP and metabolomics	Active ingredient: quercetin

↓ PRKCA and sphingolipid signaling pathways

	[136]	
Xiaojijinzhan decoction	Colorectal cancer	NP and transcriptomics	Inhibiting the metastatic and invasive abilities of colorectal cancer by modulating the VDR-TGF-β signaling pathway	[137]	
Mufangji decoction	Lung cancer	NP and transcriptomics	Active ingredient: sinomenine and dehydrocostus lactone

↑ MPO and immune pathways

	[138]	
Bushen-Jianpi-Jiedu decoction	Colorectal cancer	NP and transcriptomics and proteomics	Combined with oxaliplatin can regulate various plasma proteins (↑ ZEB2 and CAT; ↓ IL-1A and CD5L)	[139]	
Feiyanning formula	Lung cancer	NP and metabolomics	Promoting metabolism and activating mitochondrial pathways to induce apoptosis in cancer cells	[140]	
Qingyihuaji formula	Pancreatic cancer	NP and proteomics	Active ingredient: quercetin

↓ MAPK/ERK and PI3K/Akt/mTOR signaling pathways

	[141]	
Gegen Qinlian fecoction	Colorectal cancer	NP and transcriptomics	The active ingredients in Jun and Chen medicine exhibit a synergistic effect on the Wnt signaling pathway	[142]	
Xihuang pill	Lung cancer	NP and transcriptomics	Targeting CACNA1C to modulate the TME	[143]	
Traditional Chinese herbs	Astragalus membranaceus	Liver cancer	NP and transcriptomics	Active ingredient: quercetin

↓ MT1G to activate iron-dependent cell death

	[144]	
Rhus chinensis Mill	Colorectal cancer	NP and metabolomics	Targeting ENO1 and ALDOA, and regulating glycolysis and glutamine metabolism pathways	[145]	
Codonopsis pilosula	Liver cancer	NP and transcriptomics	Active ingredient: mogroside, capsaicin, and sulforaphane

↑ HMOX1 and modulating of mineral uptake pathways

	[146]	
Radix Ophiopogonis	Nasopharyngeal carcinoma	NP and proteomics	Targeting VEGFA, TP53, and HSPA8 and modulating PI3K-Akt, Wnt, cAMP signaling pathways	[147]	
Taraxacum mongolicum	Breast cancer	NP and metabolomics	Regulating the cell cycle and metabolic pathways	[148]	

Traditional Chinese medicine formulas

Li et al. [136] conducted in vivo experiments and found that WJT (an herbal formula) inhibited the development of Lewis lung carcinoma and considerably prolonged the survival of mice. Then, researchers utilized NP to determine quercetin as the principal active constituent of WJT, with protein kinase C alpha (PRKCA) being its primary target [136]. Meanwhile, metabolomics analysis indicated that WJT partially rectified the metabolic imbalance induced by lung cancer; in the analysis, sphingosine-1-phosphate was identified as a prominent differential metabolite [136]. These results indicated that WJT exerts its antitumor effects primarily by inhibiting the PRKCA/SPHK/S1P signaling pathway and the anti-apoptotic signaling pathway [136]. By implementing NP, the Feiyanning formula (FYN) was found to exert anti-lung cancer effects by activating the mitochondrial pathway [140]. Meanwhile, the results of metabolomics showed that FYN reduced the levels of putrescine and agmatine and increase in ATP utilization in A549 cells [140]. Following FYN treatment in vitro, the mitochondrial membrane potential decreased and the expression of calcium-binding proteins increased on the cell surface, which further supported the predicted results [140].

Traditional Chinese herbs

Qu et al. [148] identified 12 bioactive constituents in Dandelion using LC-Q-TOF/MS and found 50 targets associated with TNBC that were significantly enriched in cell cycle and metabolism-related pathways through NP analysis [148]. The results of a metabolomics analysis revealed 22 altered metabolites, including changes in pathways related to arginine and proline metabolism, which matched the predicted pathways from the network pharmacology analysis [148]. These findings elucidated the anti-breast cancer effects of Dandelion through the modulation of cell cycle and metabolism pathways.

Discussion and prospects

The progression from normal cells to tumor cells is an extremely complex process, during which tumor cells acquire various capabilities, including but not limited to sustained proliferation, resistance to programmed cell death, invasion and metastasis abilities, cellular metabolic reprogramming, and evasion of the immune system through continuous mutations [1]. The development of tumors is also closely associated with changes in the tumor microenvironment and the gut microbiota [149, 150]. Unlike Western medical strategies for tumor treatment, traditional Chinese herbs and herbal formulations have highly complex chemical compositions, which often act on multiple targets and inhibit tumor development through multiple pathways. For example, ginseng contains multiple antitumor active components, such as ginsenosides (Rh2, Rg3, Rg5, etc.), ginseng polysaccharides, and ginsenoids. It exerts antitumor effects or enhances the antitumor effect of chemotherapeutic agents through various mechanisms, including the inhibition of proliferation, invasion, and metastasis, improvement of the TME, immune modulation, and regulation of the gut microbiota [114, 151, 152]. Therefore, when elucidating the mechanisms underlying the antitumor effects of TCM, especially complex formulas, a research approach based on a single target pathway or characterization of the activity of a single active component cannot represent their complex network of antitumor mechanisms.

Due to continuous advancements in separation and analysis technologies, omics techniques have provided new ways to study the antitumor mechanisms of TCM. High-throughput transcriptomics and proteomics can aid researchers in identifying key anti-cancer pathways or candidate targets in TCM treatments for cancer. For instance, Chen et al. [21] identified PDGFRβ as the target of Biejiajian pill in liver cancer using RNA-seq technology. Li et al. [91] revealed through proteomics that the anti-colorectal cancer effects of atractylenolide I (ATI) are closely related to autophagy activation and downregulation of d-DT. Microbiomics such as 16S rRNA-seq and metagenomics can provide information on the different bacterial genera and species present in the gut microbiota, including the relative abundance of beneficial, harmful, and other microorganisms. This information is valuable for assessing the impact of TCM interventions on the gut microbiota, which has been shown to be a crucial pathway for its anti-tumor effects [41]. For example, Zhang et al. [109] demonstrated that Glycyrrhiza uralensis polysaccharide (GCP) exerts its anti-tumor effects by closely interacting with the gut microbiota through 16S rRNA-seq and FMT experiments. Additionally, metabolomics elucidates the mechanisms of TCM's anti-tumor effects by analyzing changes in metabolites from tumor cells/tissues or the gut microbiota. This is of significant importance for studying how TCM exerts its anti-tumor effects through various metabolic pathways, particularly lipid metabolism, or through microbiota-derived metabolites. Single-cell omics focuses on the heterogeneity among individual cells within a sample, enabling the identification of different cell subpopulations and their unique functions. This is of profound significance for both tumor and immune cells. Currently, many researchers are beginning to explore the role of single-cell omics in the study of TCM's anti-tumor and immune effects [118–120]. In summary, omics technologies have greatly advanced the field of TCM for cancer treatment, providing new methods and perspectives.

Single-omics technologies have certain limitations, as biological systems are interconnected and dynamic. Interpreting the anti-tumor effects of TCM solely at the level of transcription or protein often overlooks the regulatory relationships between these layers. Multi-omics technologies can reveal the intricate therapeutic mechanisms of traditional Chinese medicine for various diseases from different levels and illustrate the interactions among them [153]. In cancer research, the combination of transcriptomics and proteomics is common. Integrating DEGs and DAPs (usually in objects with significant changes at both levels) and further analysis (such as PPI) are used to explore potential traditional TCM anti-tumor candidate targets for subsequent research. A study by Liang et al. predicted multiple anti-tumor targets of Wenjing granules (such as SOD2, NOTCH1) through the combined analysis of the two omics [121]. The protein and metabolite networks are closely interrelated. In tumors, mutations in metabolic enzymes can lead to metabolic abnormalities, while metabolites can also affect protein expression or activity. For example, mutations in phosphofructokinase-1 (PFK-1) can lead to the well-known ‘Warburg effect’ [154]. Additionally, abnormal expression of fatty acid synthase (FASN) and cholesterol ester transfer protein (CETP) can result in disrupted lipid metabolism in tumors, thereby promoting survival [155, 156]. Therefore, the integration of transcriptomics/proteomics and metabolomics is commonly employed to investigate the intricate regulation between the proteome and metabolome in tumors following TCM interventions [122, 125]. Moreover, the combined use of microbiomics and metabolomics has successfully deciphered the changes in gut microbiota metabolism following TCM intervention (particularly bile acid and fatty acid metabolism), further elucidating the importance of gut microbiota in the anti-tumor effects of TCM. In conclusion, multi-omics techniques are of great significance in the study of the anti-tumor effects of TCM, and will effectively elucidate the complex mechanisms involved in the anti-tumor actions of TCM.

Although omics technologies are powerful tools for determining the mechanisms underlying the antitumor effects of TCM, they have some limitations. Firstly, although many researchers have determined the antitumor effects of TCM and the underlying mechanisms through multi-omics approaches, most studies have focused on independent analysis of each omics level and thus deeper insights into the regulatory relationships between different omics layers are needed. Secondly, although omics technologies can be used to identify potential antitumor molecular targets of TCM, there is limited research exploring which active ingredients may bind to them. Lastly, cutting-edge omics technologies such as single-cell/spatial omics and SMRT-seq have not yet been integrated with studies on the antitumor effects of TCM.

To summarize, omics technologies serve as powerful tools for elucidating the mechanism of action of TCM, and their application has already shown promising results. Meanwhile, the field of omics technologies are currently experiencing rapid advancement, with the emergence of innovative techniques such as single-cell omics and spatial omics. In the foreseeable future, these advancements are anticipated to offer substantial assistance in elucidating the anti-tumor mechanisms of Chinese medicine.

Abbreviations

ACE Astragalus mongholicus Bunge-Curcuma aromatica Salisb extract

Atg7 Autophagy-related 7

ATI Atractylenolide I

BFL Bufalin

BUB1B Budding uninhibited by benzimidazoles 1 homolog beta

CBF Cinobufagin

CDK1 CDK inhibitor 1

cDNA Complementary deoxyribonucleic acid

CEL-seq Cellular indexing of transcriptomes and epitopes by sequencing

cGMP Cyclic guanosine monophosphate

CITE-seq Cellular indexing of transcriptomes and epitopes by sequencing

CKI Compound kushen injection

CXCR4 C-X-C motif chemokine receptor 4

DAPs Differentially abundant proteins

DDA Data-dependent acquisition

d-DT D-Dopachrome tautomerase

DEGs Differentially expressed genes

DIA/SWATH Data independent acquisition/sequential window acquisition of all theoretical spectra

DNA Deoxyribonucleic acid

Drop-seq Droplet-based single-cell RNA sequencing

FYN Feiyanning formula

G&T-seq Genome and transcriptome sequencing

GC–MS Gas chromatography-mass spectrometry

GO Gene ontology

GPs Ginseng polysaccharides

GS Glutamine synthetase

HIF-1 Hypoxia-inducible factor 1

HMOX1 Heme oxygenase 1

IFN-γ Interferon gamma

IL-2 Interleukin-2

In Drop Indexed droplet single-cell RNA sequencing

IPA Ingenuity pathway analysis

JAK-1 Tyrosine-protein kinas

KEGG Kyoto encyclopedia of genes and genomes

Kyn/Trp L-Kynurenine/tryptophan

LC3B Microtubule-associated proteins 1A/1B light chain 3B

LC–MS Liquid chromatography-mass spectrometry

LDH Lactate dehydrogenase

MAPK Mitogen-activated protein kinase

MAPK14 Mitogen-activated protein kinase 14

MCM7 Minichromosome maintenance complex component 7

MMP1 Matrix metalloproteinase-1

MTE Marsdenia tenacissima Extracts

NF-κB Nuclear factor kappa-B

NMR Nuclear magnetic resonance spectroscopy

NGS Next generation sequencing

NOTCH1 Neurogenic locus notch homolog protein 1

NP Network pharmacology

PCR Polymerase chain reaction

PD-1 Programmed death 1

PDGFRβ Platelet-derived growth factor receptor-β

PI3K Phosphoinositide 3-kinase

POLR2F RNA polymerase II subunit F

PPIL4 Peptidylprolyl isomerase like 4

PRKCA Protein kinase C alpha

PTX Paclitaxel

RAD51 Radiation-sensitive mutant 51

RBBP7 Retinoblastoma-binding protein 7

REAP-seq RNA end-associated purification sequencing

RRBS Reduced representation bisulfite sequencing

RRM2 Ribonucleotide reductase M2

scRNA-seq Single-cell RNA sequencing

scM&T-seq Methylome and transcriptome sequencing from single-cells

SDF-1 Stromal cell-derived factor-1

SILAC Stable-isotope labelling by amino acids in cell culture

Smart-seq Switching mechanism at the 5ʹend of RNA template sequencing

SOD2 Recombinant human superoxide dismutase

SRXN1 Sulfiredoxin 1

TCM Traditional Chinese medicine

TME Tumor microenvironment

TMT/iTRAQ Tandem mass tags/isobaric tag for relative absolute quantitation

TNBC Triple-negative breast cancer

WNG Wening granules

XHP Xihuang pill

YAP Yes-associated protein

αPD-1 Anti-programmed death-1 antibody

16S rRNA-seq 16S ribosomal RNA gene sequencing

4-MDO 4-Methoxydalbergione

Acknowledgements

Not applicable.

Author contributions

Peng Tan: Conceptualization, resources, writing—original draft, writing—review & editing. Xuejiao Wei, Huiming Huang, Fei Wang, Zhuguo Wang, Jinxin Xie, Longyan Wang, and Dongxiao Liu: formal analysis, resources, writing—original draft. Zhongdong Hu: conceptualization, resources, supervision, funding acquisition, writing—review & editing. All authors read and approved the final manuscript.

Funding

This study was financially supported by the Beijing Natural Science Foundation (J230034), the National Natural Science Foundation of China (82074072, 81873044), the Fundamental Research Funds for the Central Universities (2023-JYB-JBQN-051), and the Talent Cultivation Project of Beijing University of Chinese Medicine (JZPY202206).

Availability of data and materials

All data used in this systematic review are fully available in the public domain.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

All authors declare no conflict of interest.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Hanahan D Hallmarks of cancer: new dimensions Cancer Discov 2022 12 31 46 10.1158/2159-8290.CD-21-1059 35022204
Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31–46.35022204 10.1158/2159-8290.CD-21-1059
2. Sung H Ferlay J Siegel RL Laversanne M Soerjomataram I Jemal A Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 2021 71 209 249 10.3322/caac.21660 33538338
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.33538338 10.3322/caac.21660
3. Barker HE Paget JT Khan AA Harrington KJ The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence Nat Rev Cancer 2015 15 409 425 10.1038/nrc3958 26105538
Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15:409–25.26105538 10.1038/nrc3958
4. De Ruysscher D Niedermann G Burnet NG Siva S Lee AWM Hegi-Johnson F Radiotherapy toxicity Nat Rev Dis Primers 2019 5 13 10.1038/s41572-019-0064-5 30792503
De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-Johnson F. Radiotherapy toxicity. Nat Rev Dis Primers. 2019;5:13.30792503 10.1038/s41572-019-0064-5
5. Bukowski K Kciuk M Kontek R Mechanisms of multidrug resistance in cancer chemotherapy Int J Mol Sci 2020 21 3233 10.3390/ijms21093233 32370233
Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020;21:3233.32370233 10.3390/ijms21093233
6. Yuan H Ma Q Ye L Piao G The Traditional Medicine and modern medicine from natural products Molecules 2016 21 559 10.3390/molecules21050559 27136524
Yuan H, Ma Q, Ye L, Piao G. The Traditional Medicine and modern medicine from natural products. Molecules. 2016;21:559.27136524 10.3390/molecules21050559
7. Li W Hu X Wang S Jiao Z Sun T Liu T Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation Int J Biol Macromol 2020 145 985 997 10.1016/j.ijbiomac.2019.09.189 31669273
Li W, Hu X, Wang S, Jiao Z, Sun T, Liu T, et al. Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation. Int J Biol Macromol. 2020;145:985–97.31669273 10.1016/j.ijbiomac.2019.09.189
8. Song J Chen Y He D Tan W Lv F Liang B Astragalus polysaccharide promotes adriamycin-induced apoptosis in gastric cancer cells Cancer Manag Res 2020 12 2405 2414 10.2147/CMAR.S237146 32280276
Song J, Chen Y, He D, Tan W, Lv F, Liang B, et al. Astragalus polysaccharide promotes adriamycin-induced apoptosis in gastric cancer cells. Cancer Manag Res. 2020;12:2405–14.32280276 10.2147/CMAR.S237146
9. Li C Chen W Zhang M Zhang C Cao B Dong B Modulatory effects of Xihuang Pill on lung cancer treatment by an integrative approach Biomed Pharmacother 2020 130 110533 10.1016/j.biopha.2020.110533 32739739
Li C, Chen W, Zhang M, Zhang C, Cao B, Dong B, et al. Modulatory effects of Xihuang Pill on lung cancer treatment by an integrative approach. Biomed Pharmacother. 2020;130: 110533.32739739 10.1016/j.biopha.2020.110533
10. Xu L Duan H Zou Y Wang J Liu H Wang W Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2 Phytomedicine 2023 114 154764 10.1016/j.phymed.2023.154764 36963368
Xu L, Duan H, Zou Y, Wang J, Liu H, Wang W, et al. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2. Phytomedicine. 2023;114: 154764.36963368 10.1016/j.phymed.2023.154764
11. Su L Jiang Y Xu Y Li X Gao W Xu C Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathway Biomed Pharmacother 2018 102 1111 1119 10.1016/j.biopha.2018.03.063 29710529
Su L, Jiang Y, Xu Y, Li X, Gao W, Xu C, et al. Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathway. Biomed Pharmacother. 2018;102:1111–9.29710529 10.1016/j.biopha.2018.03.063
12. Bao Y Wang S Yang X Li T Xia Y Meng X Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS J Ethnopharmacol 2017 198 468 478 10.1016/j.jep.2017.01.029 28108381
Bao Y, Wang S, Yang X, Li T, Xia Y, Meng X. Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS. J Ethnopharmacol. 2017;198:468–78.28108381 10.1016/j.jep.2017.01.029
13. Hasin Y Seldin M Lusis A Multi-omics approaches to disease Genome Biol 2017 18 83 10.1186/s13059-017-1215-1 28476144
Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017;18:83.28476144 10.1186/s13059-017-1215-1
14. Guo R Luo X Liu J Liu L Wang X Lu H Omics strategies decipher therapeutic discoveries of traditional Chinese medicine against different diseases at multiple layers molecular-level Pharmacol Res 2020 152 104627 10.1016/j.phrs.2020.104627 31904505
Guo R, Luo X, Liu J, Liu L, Wang X, Lu H. Omics strategies decipher therapeutic discoveries of traditional Chinese medicine against different diseases at multiple layers molecular-level. Pharmacol Res. 2020;152: 104627.31904505 10.1016/j.phrs.2020.104627
15. Goos H Kinnunen M Salokas K Tan Z Liu X Yadav L Human transcription factor protein interaction networks Nat Commun 2022 13 766 10.1038/s41467-022-28341-5 35140242
Goos H, Kinnunen M, Salokas K, Tan Z, Liu X, Yadav L, et al. Human transcription factor protein interaction networks. Nat Commun. 2022;13:766.35140242 10.1038/s41467-022-28341-5
16. Yerly L Pich-Bavastro C Di Domizio J Wyss T Tissot-Renaud S Cangkrama M Integrated multi-omics reveals cellular and molecular interactions governing the invasive niche of basal cell carcinoma Nat Commun 2022 13 4897 10.1038/s41467-022-32670-w 35986012
Yerly L, Pich-Bavastro C, Di Domizio J, Wyss T, Tissot-Renaud S, Cangkrama M, et al. Integrated multi-omics reveals cellular and molecular interactions governing the invasive niche of basal cell carcinoma. Nat Commun. 2022;13:4897.35986012 10.1038/s41467-022-32670-w
17. Tang X Huang Y Lei J Luo H Zhu X The single-cell sequencing: new developments and medical applications Cell Biosci 2019 9 53 10.1186/s13578-019-0314-y 31391919
Tang X, Huang Y, Lei J, Luo H, Zhu X. The single-cell sequencing: new developments and medical applications. Cell Biosci. 2019;9:53.31391919 10.1186/s13578-019-0314-y
18. Haince JF Joubert P Bach H Ahmed Bux R Tappia PS Ramjiawan B Metabolomic fingerprinting for the detection of early-stage lung cancer: from the genome to the metabolome Int J Mol Sci 2022 23 1215 10.3390/ijms23031215 35163138
Haince JF, Joubert P, Bach H, Ahmed Bux R, Tappia PS, Ramjiawan B. Metabolomic fingerprinting for the detection of early-stage lung cancer: from the genome to the metabolome. Int J Mol Sci. 2022;23:1215.35163138 10.3390/ijms23031215
19. Germon A Heesom KJ Amoah R Adams JC Protein disulfide isomerase A3 activity promotes extracellular accumulation of proteins relevant to basal breast cancer outcomes in human MDA-MB-A231 breast cancer cells Am J Physiol Cell Physiol 2023 324 C113 C132 10.1152/ajpcell.00445.2022 36374169
Germon A, Heesom KJ, Amoah R, Adams JC. Protein disulfide isomerase A3 activity promotes extracellular accumulation of proteins relevant to basal breast cancer outcomes in human MDA-MB-A231 breast cancer cells. Am J Physiol Cell Physiol. 2023;324:C113–32.36374169 10.1152/ajpcell.00445.2022
20. Li J Zhao C Xu Y Song L Chen Y Xu Y Remodeling of the osteoimmune microenvironment after biomaterials implantation in murine tibia: single-cell transcriptome analysis Bioact Mater 2023 22 404 422 36311047
Li J, Zhao C, Xu Y, Song L, Chen Y, Xu Y, et al. Remodeling of the osteoimmune microenvironment after biomaterials implantation in murine tibia: single-cell transcriptome analysis. Bioact Mater. 2023;22:404–22.36311047
21. Chen W Yang X Sun J Chen Y Zhao W He C Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRbeta signaling in cancer-associated fibroblasts J Ethnopharmacol 2023 301 115825 10.1016/j.jep.2022.115825 36240978
Chen W, Yang X, Sun J, Chen Y, Zhao W, He C, et al. Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRbeta signaling in cancer-associated fibroblasts. J Ethnopharmacol. 2023;301: 115825.36240978 10.1016/j.jep.2022.115825
22. Heller MJ DNA microarray technology: devices, systems, and applications Annu Rev Biomed Eng 2002 4 129 153 10.1146/annurev.bioeng.4.020702.153438 12117754
Heller MJ. DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng. 2002;4:129–53.12117754 10.1146/annurev.bioeng.4.020702.153438
23. Goodwin S McPherson JD McCombie WR Coming of age: ten years of next-generation sequencing technologies Nat Rev Genet 2016 17 333 351 10.1038/nrg.2016.49 27184599
Goodwin S, McPherson JD, McCombie WR. Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet. 2016;17:333–51.27184599 10.1038/nrg.2016.49
24. Wang Z Gerstein M Snyder M RNA-Seq: a revolutionary tool for transcriptomics Nat Rev Genet 2009 10 57 63 10.1038/nrg2484 19015660
Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10:57–63.19015660 10.1038/nrg2484
25. Barreto K Maruthachalam BV Hill W Hogan D Sutherland AR Kusalik A Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputs Nucleic Acids Res 2019 47 e50 10.1093/nar/gkz131 30854567
Barreto K, Maruthachalam BV, Hill W, Hogan D, Sutherland AR, Kusalik A, et al. Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputs. Nucleic Acids Res. 2019;47: e50.30854567 10.1093/nar/gkz131
26. Aguilar-Lopez M Dinsmoor AM Ho TTB Donovan SM A systematic review of the factors influencing microbial colonization of the preterm infant gut Gut Microbes 2021 13 1 33 10.1080/19490976.2021.1884514 33818293
Aguilar-Lopez M, Dinsmoor AM, Ho TTB, Donovan SM. A systematic review of the factors influencing microbial colonization of the preterm infant gut. Gut Microbes. 2021;13:1–33.33818293 10.1080/19490976.2021.1884514
27. van Dijk EL Jaszczyszyn Y Naquin D Thermes C The third revolution in sequencing technology Trends Genet 2018 34 666 681 10.1016/j.tig.2018.05.008 29941292
van Dijk EL, Jaszczyszyn Y, Naquin D, Thermes C. The third revolution in sequencing technology. Trends Genet. 2018;34:666–81.29941292 10.1016/j.tig.2018.05.008
28. Altelaar AF Munoz J Heck AJ Next-generation proteomics: towards an integrative view of proteome dynamics Nat Rev Genet 2013 14 35 48 10.1038/nrg3356 23207911
Altelaar AF, Munoz J, Heck AJ. Next-generation proteomics: towards an integrative view of proteome dynamics. Nat Rev Genet. 2013;14:35–48.23207911 10.1038/nrg3356
29. Neilson KA Ali NA Muralidharan S Mirzaei M Mariani M Assadourian G Less label, more free: approaches in label-free quantitative mass spectrometry Proteomics 2011 11 535 553 10.1002/pmic.201000553 21243637
Neilson KA, Ali NA, Muralidharan S, Mirzaei M, Mariani M, Assadourian G, et al. Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics. 2011;11:535–53.21243637 10.1002/pmic.201000553
30. Gillet LC Navarro P Tate S Rost H Selevsek N Reiter L Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis Mol Cell Proteomics 2012 11 O111 016717
Gillet LC, Navarro P, Tate S, Rost H, Selevsek N, Reiter L, et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics. 2012;11(O111): 016717.
31. Sidoli S Fujiwara R Garcia BA Multiplexed data independent acquisition (MSX-DIA) applied by high resolution mass spectrometry improves quantification quality for the analysis of histone peptides Proteomics 2016 16 2095 2105 10.1002/pmic.201500527 27193262
Sidoli S, Fujiwara R, Garcia BA. Multiplexed data independent acquisition (MSX-DIA) applied by high resolution mass spectrometry improves quantification quality for the analysis of histone peptides. Proteomics. 2016;16:2095–105.27193262 10.1002/pmic.201500527
32. Chen X Wei S Ji Y Guo X Yang F Quantitative proteomics using SILAC: principles, applications, and developments Proteomics 2015 15 3175 3192 10.1002/pmic.201500108 26097186
Chen X, Wei S, Ji Y, Guo X, Yang F. Quantitative proteomics using SILAC: principles, applications, and developments. Proteomics. 2015;15:3175–92.26097186 10.1002/pmic.201500108
33. Zieske LR A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies J Exp Bot 2006 57 1501 1508 10.1093/jxb/erj168 16574745
Zieske LR. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot. 2006;57:1501–8.16574745 10.1093/jxb/erj168
34. Yin H Zhu J Methods for quantification of glycopeptides by liquid separation and mass spectrometry Mass Spectrom Rev 2023 42 887 917 10.1002/mas.21771 35099083
Yin H, Zhu J. Methods for quantification of glycopeptides by liquid separation and mass spectrometry. Mass Spectrom Rev. 2023;42:887–917.35099083 10.1002/mas.21771
35. Zhou Y Lih TM Pan J Hoti N Dong M Cao L Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets J Hematol Oncol 2020 13 170 10.1186/s13045-020-01013-x 33287876
Zhou Y, Lih TM, Pan J, Hoti N, Dong M, Cao L, et al. Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets. J Hematol Oncol. 2020;13:170.33287876 10.1186/s13045-020-01013-x
36. Wang R Li B Lam SM Shui G Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression J Genet Genomics 2020 47 69 83 10.1016/j.jgg.2019.11.009 32178981
Wang R, Li B, Lam SM, Shui G. Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression. J Genet Genomics. 2020;47:69–83.32178981 10.1016/j.jgg.2019.11.009
37. Fiehn O Metabolomics by gas chromatography-mass spectrometry: combined targeted and untargeted profiling Curr Protoc Mol Biol 2016 114 30 4 1 30 4 32 27038389
Fiehn O. Metabolomics by gas chromatography-mass spectrometry: combined targeted and untargeted profiling. Curr Protoc Mol Biol. 2016;114:30 4 1-30 4 32.27038389
38. Zeki OC Eylem CC Recber T Kir S Nemutlu E Integration of GC-MS and LC-MS for untargeted metabolomics profiling J Pharm Biomed Anal 2020 190 113509 10.1016/j.jpba.2020.113509 32814263
Zeki OC, Eylem CC, Recber T, Kir S, Nemutlu E. Integration of GC-MS and LC-MS for untargeted metabolomics profiling. J Pharm Biomed Anal. 2020;190: 113509.32814263 10.1016/j.jpba.2020.113509
39. Zhang A Sun H Wang P Han Y Wang X Modern analytical techniques in metabolomics analysis Analyst 2012 137 293 300 10.1039/C1AN15605E 22102985
Zhang A, Sun H, Wang P, Han Y, Wang X. Modern analytical techniques in metabolomics analysis. Analyst. 2012;137:293–300.22102985 10.1039/C1AN15605E
40. Weinstock GM Genomic approaches to studying the human microbiota Nature 2012 489 250 256 10.1038/nature11553 22972298
Weinstock GM. Genomic approaches to studying the human microbiota. Nature. 2012;489:250–6.22972298 10.1038/nature11553
41. Laudadio I Fulci V Palone F Stronati L Cucchiara S Carissimi C Quantitative assessment of shotgun metagenomics and 16S rDNA amplicon sequencing in the study of human gut microbiome OMICS 2018 22 248 254 10.1089/omi.2018.0013 29652573
Laudadio I, Fulci V, Palone F, Stronati L, Cucchiara S, Carissimi C. Quantitative assessment of shotgun metagenomics and 16S rDNA amplicon sequencing in the study of human gut microbiome. OMICS. 2018;22:248–54.29652573 10.1089/omi.2018.0013
42. Ranjan R Rani A Metwally A McGee HS Perkins DL Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing Biochem Biophys Res Commun 2016 469 967 977 10.1016/j.bbrc.2015.12.083 26718401
Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL. Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun. 2016;469:967–77.26718401 10.1016/j.bbrc.2015.12.083
43. Johnson JS Spakowicz DJ Hong BY Petersen LM Demkowicz P Chen L Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis Nat Commun 2019 10 5029 10.1038/s41467-019-13036-1 31695033
Johnson JS, Spakowicz DJ, Hong BY, Petersen LM, Demkowicz P, Chen L, et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun. 2019;10:5029.31695033 10.1038/s41467-019-13036-1
44. Yang L Fan W Xu Y Metaproteomics insights into traditional fermented foods and beverages Compr Rev Food Sci Food Saf 2020 19 2506 2529 10.1111/1541-4337.12601 33336970
Yang L, Fan W, Xu Y. Metaproteomics insights into traditional fermented foods and beverages. Compr Rev Food Sci Food Saf. 2020;19:2506–29.33336970 10.1111/1541-4337.12601
45. Bauermeister A Mannochio-Russo H Costa-Lotufo LV Jarmusch AK Dorrestein PC Mass spectrometry-based metabolomics in microbiome investigations Nat Rev Microbiol 2022 20 143 160 10.1038/s41579-021-00621-9 34552265
Bauermeister A, Mannochio-Russo H, Costa-Lotufo LV, Jarmusch AK, Dorrestein PC. Mass spectrometry-based metabolomics in microbiome investigations. Nat Rev Microbiol. 2022;20:143–60.34552265 10.1038/s41579-021-00621-9
46. Lei Y Tang R Xu J Wang W Zhang B Liu J Applications of single-cell sequencing in cancer research: progress and perspectives J Hematol Oncol 2021 14 91 10.1186/s13045-021-01105-2 34108022
Lei Y, Tang R, Xu J, Wang W, Zhang B, Liu J, et al. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol. 2021;14:91.34108022 10.1186/s13045-021-01105-2
47. Svensson V Vento-Tormo R Teichmann SA Exponential scaling of single-cell RNA-seq in the past decade Nat Protoc 2018 13 599 604 10.1038/nprot.2017.149 29494575
Svensson V, Vento-Tormo R, Teichmann SA. Exponential scaling of single-cell RNA-seq in the past decade. Nat Protoc. 2018;13:599–604.29494575 10.1038/nprot.2017.149
48. Abugessaisa I Hasegawa A Noguchi S Cardon M Watanabe K Takahashi M SkewC: identifying cells with skewed gene body coverage in single-cell RNA sequencing data iScience 2022 25 103777 10.1016/j.isci.2022.103777 35146392
Abugessaisa I, Hasegawa A, Noguchi S, Cardon M, Watanabe K, Takahashi M, et al. SkewC: identifying cells with skewed gene body coverage in single-cell RNA sequencing data. iScience. 2022;25: 103777.35146392 10.1016/j.isci.2022.103777
49. Rodriguez-Meira A Buck G Clark SA Povinelli BJ Alcolea V Louka E Unravelling intratumoral heterogeneity through high-sensitivity single-cell mutational analysis and parallel RNA sequencing Mol Cell 2019 73 1292–305 e8
Rodriguez-Meira A, Buck G, Clark SA, Povinelli BJ, Alcolea V, Louka E, et al. Unravelling intratumoral heterogeneity through high-sensitivity single-cell mutational analysis and parallel RNA sequencing. Mol Cell. 2019;73(1292–305): e8.
50. Macaulay IC Haerty W Kumar P Li YI Hu TX Teng MJ G&T-seq: parallel sequencing of single-cell genomes and transcriptomes Nat Methods 2015 12 519 522 10.1038/nmeth.3370 25915121
Macaulay IC, Haerty W, Kumar P, Li YI, Hu TX, Teng MJ, et al. G&T-seq: parallel sequencing of single-cell genomes and transcriptomes. Nat Methods. 2015;12:519–22.25915121 10.1038/nmeth.3370
51. Chen S Lake BB Zhang K High-throughput sequencing of the transcriptome and chromatin accessibility in the same cell Nat Biotechnol 2019 37 1452 1457 10.1038/s41587-019-0290-0 31611697
Chen S, Lake BB, Zhang K. High-throughput sequencing of the transcriptome and chromatin accessibility in the same cell. Nat Biotechnol. 2019;37:1452–7.31611697 10.1038/s41587-019-0290-0
52. Angermueller C Clark SJ Lee HJ Macaulay IC Teng MJ Hu TX Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity Nat Methods 2016 13 229 232 10.1038/nmeth.3728 26752769
Angermueller C, Clark SJ, Lee HJ, Macaulay IC, Teng MJ, Hu TX, et al. Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity. Nat Methods. 2016;13:229–32.26752769 10.1038/nmeth.3728
53. Stoeckius M Hafemeister C Stephenson W Houck-Loomis B Chattopadhyay PK Swerdlow H Simultaneous epitope and transcriptome measurement in single cells Nat Methods 2017 14 865 868 10.1038/nmeth.4380 28759029
Stoeckius M, Hafemeister C, Stephenson W, Houck-Loomis B, Chattopadhyay PK, Swerdlow H, et al. Simultaneous epitope and transcriptome measurement in single cells. Nat Methods. 2017;14:865–8.28759029 10.1038/nmeth.4380
54. Peterson VM Zhang KX Kumar N Wong J Li L Wilson DC Multiplexed quantification of proteins and transcripts in single cells Nat Biotechnol 2017 35 936 939 10.1038/nbt.3973 28854175
Peterson VM, Zhang KX, Kumar N, Wong J, Li L, Wilson DC, et al. Multiplexed quantification of proteins and transcripts in single cells. Nat Biotechnol. 2017;35:936–9.28854175 10.1038/nbt.3973
55. Yang X Yang R Zhang Y Shi Y Ma M Li F Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPARgamma/AMPK signaling pathway Biomed Pharmacother 2023 165 115164 10.1016/j.biopha.2023.115164 37478577
Yang X, Yang R, Zhang Y, Shi Y, Ma M, Li F, et al. Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPARgamma/AMPK signaling pathway. Biomed Pharmacother. 2023;165: 115164.37478577 10.1016/j.biopha.2023.115164
56. Zhang Z Wang J Duan H Liu D Zhou X Lin X Traditional Chinese Medicine Xihuang Wan inhibited lewis lung carcinoma in a syngeneic model, equivalent to cytotoxic chemotherapy, by altering multiple signaling pathways In Vivo 2021 35 2005 2014 10.21873/invivo.12469 34182475
Zhang Z, Wang J, Duan H, Liu D, Zhou X, Lin X, et al. Traditional Chinese Medicine Xihuang Wan inhibited lewis lung carcinoma in a syngeneic model, equivalent to cytotoxic chemotherapy, by altering multiple signaling pathways. In Vivo. 2021;35:2005–14.34182475 10.21873/invivo.12469
57. Kong L Liu X Yu B Yuan Y Zhao Q Chen Y Cinobufacini injection inhibits the proliferation of triple-negative breast cancer through the Pin1-TAZ signaling pathway Front Pharmacol 2022 13 797873 10.3389/fphar.2022.797873 35450041
Kong L, Liu X, Yu B, Yuan Y, Zhao Q, Chen Y, et al. Cinobufacini injection inhibits the proliferation of triple-negative breast cancer through the Pin1-TAZ signaling pathway. Front Pharmacol. 2022;13: 797873.35450041 10.3389/fphar.2022.797873
58. Chen J Feng L Jin W Chang J Li J Li H Identification of the key active pharmaceutical ingredients of Yishen Qutong Granule, a Chinese Medicine formula, in the treatment of primary lung cancer Comb Chem High Throughput Screen 2023 26 1594 1608 10.2174/1386207326666221207152001 36503468
Chen J, Feng L, Jin W, Chang J, Li J, Li H. Identification of the key active pharmaceutical ingredients of Yishen Qutong Granule, a Chinese Medicine formula, in the treatment of primary lung cancer. Comb Chem High Throughput Screen. 2023;26:1594–608.36503468 10.2174/1386207326666221207152001
59. Zhao B Hui X Jiao L Bi L Wang L Huang P A TCM formula YYWY inhibits tumor growth in non-small cell lung cancer and enhances immune-response through facilitating the maturation of dendritic cells Front Pharmacol 2020 11 798 10.3389/fphar.2020.00798 32595493
Zhao B, Hui X, Jiao L, Bi L, Wang L, Huang P, et al. A TCM formula YYWY inhibits tumor growth in non-small cell lung cancer and enhances immune-response through facilitating the maturation of dendritic cells. Front Pharmacol. 2020;11:798.32595493 10.3389/fphar.2020.00798
60. Ding X Yang Q Kong X Haffty BG Gao S Moran MS Radiosensitization effect of Huaier on breast cancer cells Oncol Rep 2016 35 2843 2850 10.3892/or.2016.4630 26935024
Ding X, Yang Q, Kong X, Haffty BG, Gao S, Moran MS. Radiosensitization effect of Huaier on breast cancer cells. Oncol Rep. 2016;35:2843–50.26935024 10.3892/or.2016.4630
61. Peng C Zhang W Dai C Li W Shen X Yuan Y Study of the aqueous extract of Aloe vera and its two active components on the Wnt/beta-catenin and Notch signaling pathways in colorectal cancer cells J Ethnopharmacol 2019 243 112092 10.1016/j.jep.2019.112092 31319122
Peng C, Zhang W, Dai C, Li W, Shen X, Yuan Y, et al. Study of the aqueous extract of Aloe vera and its two active components on the Wnt/beta-catenin and Notch signaling pathways in colorectal cancer cells. J Ethnopharmacol. 2019;243: 112092.31319122 10.1016/j.jep.2019.112092
62. Kang JX Liu J Wang J He C Li FP The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells Carcinogenesis 2005 26 1934 1939 10.1093/carcin/bgi154 15958519
Kang JX, Liu J, Wang J, He C, Li FP. The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells. Carcinogenesis. 2005;26:1934–9.15958519 10.1093/carcin/bgi154
63. Li R Xu CQ Shen JX Ren QY Chen DL Lin MJ 4-Methoxydalbergione is a potent inhibitor of human astroglioma U87 cells in vitro and in vivo Acta Pharmacol Sin 2021 42 1507 1515 10.1038/s41401-020-00560-w 33311599
Li R, Xu CQ, Shen JX, Ren QY, Chen DL, Lin MJ, et al. 4-Methoxydalbergione is a potent inhibitor of human astroglioma U87 cells in vitro and in vivo. Acta Pharmacol Sin. 2021;42:1507–15.33311599 10.1038/s41401-020-00560-w
64. Zhang L Li L Chen X Yuan S Xu T Zhao W Evodiamine inhibits ESCC by inducing M-phase cell-cycle arrest via CUL4A/p53/p21 axis and activating noxa-dependent intrinsic and DR4-dependent extrinsic apoptosis Phytomedicine 2023 108 154493 10.1016/j.phymed.2022.154493 36265256
Zhang L, Li L, Chen X, Yuan S, Xu T, Zhao W, et al. Evodiamine inhibits ESCC by inducing M-phase cell-cycle arrest via CUL4A/p53/p21 axis and activating noxa-dependent intrinsic and DR4-dependent extrinsic apoptosis. Phytomedicine. 2023;108: 154493.36265256 10.1016/j.phymed.2022.154493
65. Farooq U Wang H Hu J Li G Jehan S Shi J Polydatin inhibits hepatocellular carcinoma cell proliferation and sensitizes doxorubicin and cisplatin through targeting cell mitotic machinery Cells 2023 12 222 10.3390/cells12020222 36672157
Farooq U, Wang H, Hu J, Li G, Jehan S, Shi J, et al. Polydatin inhibits hepatocellular carcinoma cell proliferation and sensitizes doxorubicin and cisplatin through targeting cell mitotic machinery. Cells. 2023;12:222.36672157 10.3390/cells12020222
66. Ma B Li J Yang WK Zhang MG Xie XD Bai ZT N-trans-feruloyloctopamine wakes Up BBC3, DDIT3, CDKN1A, and NOXA Signals to accelerate HCC cell apoptosis Anal Cell Pathol (Amst) 2021 2021 1560307 34123711
Ma B, Li J, Yang WK, Zhang MG, Xie XD, Bai ZT. N-trans-feruloyloctopamine wakes Up BBC3, DDIT3, CDKN1A, and NOXA Signals to accelerate HCC cell apoptosis. Anal Cell Pathol (Amst). 2021;2021:1560307.34123711
67. Zhang H Wang Y Zhang Y Zheng B Wang X Chen J Periplocin induces apoptosis of pancreatic cancer cells through autophagy via the AMPK/mTOR pathway J Oncol 2022 2022 8055004 35847371
Zhang H, Wang Y, Zhang Y, Zheng B, Wang X, Chen J, et al. Periplocin induces apoptosis of pancreatic cancer cells through autophagy via the AMPK/mTOR pathway. J Oncol. 2022;2022:8055004.35847371
68. Hirasaki Y Okabe A Fukuyo M Rahmutulla B Mano Y Seki M Cinobufagin inhibits proliferation of acute myeloid leukaemia cells by repressing c-Myc pathway-associated genes Chem Biol Interact 2022 360 109936 10.1016/j.cbi.2022.109936 35447139
Hirasaki Y, Okabe A, Fukuyo M, Rahmutulla B, Mano Y, Seki M, et al. Cinobufagin inhibits proliferation of acute myeloid leukaemia cells by repressing c-Myc pathway-associated genes. Chem Biol Interact. 2022;360: 109936.35447139 10.1016/j.cbi.2022.109936
69. Zheng Z Wu M Zhang J Fu W Xu N Lao Y The natural compound neobractatin induces cell cycle arrest by regulating E2F1 and Gadd45alpha Front Oncol 2019 9 654 10.3389/fonc.2019.00654 31380287
Zheng Z, Wu M, Zhang J, Fu W, Xu N, Lao Y, et al. The natural compound neobractatin induces cell cycle arrest by regulating E2F1 and Gadd45alpha. Front Oncol. 2019;9:654.31380287 10.3389/fonc.2019.00654
70. Zhou ZY Zhao WR Xiao Y Zhou XM Huang C Shi WT Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo Acta Pharmacol Sin 2020 41 260 269 10.1038/s41401-019-0291-z 31515528
Zhou ZY, Zhao WR, Xiao Y, Zhou XM, Huang C, Shi WT, et al. Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo. Acta Pharmacol Sin. 2020;41:260–9.31515528 10.1038/s41401-019-0291-z
71. Han Q Bai H Xu Y Zhou M Zhou H Dong X Solamargine induces autophagy-mediated apoptosis and enhances bortezomib activity in multiple myeloma Clin Exp Pharmacol Physiol 2022 49 674 685 10.1111/1440-1681.13643 35294057
Han Q, Bai H, Xu Y, Zhou M, Zhou H, Dong X, et al. Solamargine induces autophagy-mediated apoptosis and enhances bortezomib activity in multiple myeloma. Clin Exp Pharmacol Physiol. 2022;49:674–85.35294057 10.1111/1440-1681.13643
72. Lin KH Huang MY Cheng WC Wang SC Fang SH Tu HP RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment Sci Rep 2018 8 2672 10.1038/s41598-018-21065-x 29422643
Lin KH, Huang MY, Cheng WC, Wang SC, Fang SH, Tu HP, et al. RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment. Sci Rep. 2018;8:2672.29422643 10.1038/s41598-018-21065-x
73. Liao KF Chiu TL Huang SY Hsieh TF Chang SF Ruan JW Anti-cancer effects of radix angelica sinensis (Danggui) and N-butylidenephthalide on gastric cancer: implications for REDD1 activation and mTOR inhibition Cell Physiol Biochem 2018 48 2231 2246 10.1159/000492641 30114701
Liao KF, Chiu TL, Huang SY, Hsieh TF, Chang SF, Ruan JW, et al. Anti-cancer effects of radix angelica sinensis (Danggui) and N-butylidenephthalide on gastric cancer: implications for REDD1 activation and mTOR inhibition. Cell Physiol Biochem. 2018;48:2231–46.30114701 10.1159/000492641
74. Manzoni C Kia DA Vandrovcova J Hardy J Wood NW Lewis PA Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences Brief Bioinform 2018 19 286 302 10.1093/bib/bbw114 27881428
Manzoni C, Kia DA, Vandrovcova J, Hardy J, Wood NW, Lewis PA, et al. Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief Bioinform. 2018;19:286–302.27881428 10.1093/bib/bbw114
75. Watanabe Y Aoki-Kinoshita KF Ishihama Y Okuda S GlycoPOST realizes FAIR principles for glycomics mass spectrometry data Nucleic Acids Res 2021 49 D1523 D1528 10.1093/nar/gkaa1012 33174597
Watanabe Y, Aoki-Kinoshita KF, Ishihama Y, Okuda S. GlycoPOST realizes FAIR principles for glycomics mass spectrometry data. Nucleic Acids Res. 2021;49:D1523–8.33174597 10.1093/nar/gkaa1012
76. Fan D Liu C Li L Lu C Zhao N Shu J Deciphering antitumor mechanism of Pien Tze Huang in mice of hepatocellular carcinoma based on proteomics J Immunol Res 2020 2020 4876251 10.1155/2020/4876251 33344655
Fan D, Liu C, Li L, Lu C, Zhao N, Shu J, et al. Deciphering antitumor mechanism of Pien Tze Huang in mice of hepatocellular carcinoma based on proteomics. J Immunol Res. 2020;2020:4876251.33344655 10.1155/2020/4876251
77. An P Lu D Zhang L Lan H Yang H Ge G Synergistic antitumor effects of compound-composed optimal formula from Aidi injection on hepatocellular carcinoma and colorectal cancer Phytomedicine 2022 103 154231 10.1016/j.phymed.2022.154231 35691079
An P, Lu D, Zhang L, Lan H, Yang H, Ge G, et al. Synergistic antitumor effects of compound-composed optimal formula from Aidi injection on hepatocellular carcinoma and colorectal cancer. Phytomedicine. 2022;103: 154231.35691079 10.1016/j.phymed.2022.154231
78. Chen Y Zhang F Du Z Xie J Xia L Hou X Proteome analysis of camellia nitidissima chi revealed its role in colon cancer through the apoptosis and ferroptosis pathway Front Oncol 2021 11 727130 10.3389/fonc.2021.727130 34858814
Chen Y, Zhang F, Du Z, Xie J, Xia L, Hou X, et al. Proteome analysis of camellia nitidissima chi revealed its role in colon cancer through the apoptosis and ferroptosis pathway. Front Oncol. 2021;11: 727130.34858814 10.3389/fonc.2021.727130
79. Jia L Lin XR Guo WY Huang M Zhao Y Zhang YS Salvia chinensia Benth induces autophagy in esophageal cancer cells via AMPK/ULK1 signaling pathway Front Pharmacol 2022 13 995344 10.3389/fphar.2022.995344 36120378
Jia L, Lin XR, Guo WY, Huang M, Zhao Y, Zhang YS, et al. Salvia chinensia Benth induces autophagy in esophageal cancer cells via AMPK/ULK1 signaling pathway. Front Pharmacol. 2022;13: 995344.36120378 10.3389/fphar.2022.995344
80. Chen JF Tsai YT Lai YH Lin CC Chou HC Kuo WH Proteomic analysis of Antrodia Cinnamomea-induced ER stress in liver cancer cells J Pharm Biomed Anal 2020 187 113142 10.1016/j.jpba.2020.113142 32460214
Chen JF, Tsai YT, Lai YH, Lin CC, Chou HC, Kuo WH, et al. Proteomic analysis of Antrodia Cinnamomea-induced ER stress in liver cancer cells. J Pharm Biomed Anal. 2020;187: 113142.32460214 10.1016/j.jpba.2020.113142
81. Zhao R Zheng S Li Y Zhang X Rao D Chun Z As a novel anticancer candidate, ether extract of Dendrobium nobile overstimulates cellular protein biosynthesis to induce cell stress and autophagy J Appl Biomed 2023 21 23 35 10.32725/jab.2022.019 36708715
Zhao R, Zheng S, Li Y, Zhang X, Rao D, Chun Z, et al. As a novel anticancer candidate, ether extract of Dendrobium nobile overstimulates cellular protein biosynthesis to induce cell stress and autophagy. J Appl Biomed. 2023;21:23–35.36708715 10.32725/jab.2022.019
82. Park YM Kim MA Jung HT Kang HJ Yoo HS Kang IC Nutriproteomic analysis of hwangmaemok-induced antiangiogenic effect using antibody-arrayed protein chip assay J Med Food 2017 20 586 591 10.1089/jmf.2016.3775 28581882
Park YM, Kim MA, Jung HT, Kang HJ, Yoo HS, Kang IC. Nutriproteomic analysis of hwangmaemok-induced antiangiogenic effect using antibody-arrayed protein chip assay. J Med Food. 2017;20:586–91.28581882 10.1089/jmf.2016.3775
83. Chu Z Shi X Chen G He X Qian Y Wang H Corrigendum: COE inhibits vasculogenic mimicry by targeting EphA2 in hepatocellular carcinoma, a research based on proteomics analysis Front Pharmacol 2021 12 831941 10.3389/fphar.2021.831941 35069227
Chu Z, Shi X, Chen G, He X, Qian Y, Wang H, et al. Corrigendum: COE inhibits vasculogenic mimicry by targeting EphA2 in hepatocellular carcinoma, a research based on proteomics analysis. Front Pharmacol. 2021;12: 831941.35069227 10.3389/fphar.2021.831941
84. Hu KD Yang KG Soumia C Wu MY Yan C Li XY Proteomics analysis of Astragalus polysaccharide on TLR4-activated lung cancer cell-derived exosomes Zhongguo Zhong Yao Za Zhi 2022 47 5908 5915 36472010
Hu KD, Yang KG, Soumia C, Wu MY, Yan C, Li XY, et al. Proteomics analysis of Astragalus polysaccharide on TLR4-activated lung cancer cell-derived exosomes. Zhongguo Zhong Yao Za Zhi. 2022;47:5908–15.36472010
85. Jia L Zhou J Zhao H Jin H Lv M Zhao N Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail-glycolysis pathways Oncol Rep 2017 38 2464 2470 10.3892/or.2017.5886 28791374
Jia L, Zhou J, Zhao H, Jin H, Lv M, Zhao N, et al. Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail-glycolysis pathways. Oncol Rep. 2017;38:2464–70.28791374 10.3892/or.2017.5886
86. Li F Zhao D Yang S Wang J Liu Q Jin X ITRAQ-based proteomics analysis of triptolide on human A549 Lung adenocarcinoma cells Cell Physiol Biochem 2018 45 917 934 10.1159/000487286 29428961
Li F, Zhao D, Yang S, Wang J, Liu Q, Jin X, et al. ITRAQ-based proteomics analysis of triptolide on human A549 Lung adenocarcinoma cells. Cell Physiol Biochem. 2018;45:917–34.29428961 10.1159/000487286
87. Zhou Y Li W Wang M Zhang X Zhang H Tong X Competitive profiling of celastrol targets in human cervical cancer HeLa cells via quantitative chemical proteomics Mol Biosyst 2016 13 83 91 10.1039/C6MB00691D 27819370
Zhou Y, Li W, Wang M, Zhang X, Zhang H, Tong X, et al. Competitive profiling of celastrol targets in human cervical cancer HeLa cells via quantitative chemical proteomics. Mol Biosyst. 2016;13:83–91.27819370 10.1039/C6MB00691D
88. Akhtar N Abbasi SW Rubnawaz S Jafri L Rani R Proteomic profiling the molecular signatures of plectranthoic acid in prostate cancer cells J Proteomics 2021 246 104311 10.1016/j.jprot.2021.104311 34214676
Akhtar N, Abbasi SW, Rubnawaz S, Jafri L, Rani R. Proteomic profiling the molecular signatures of plectranthoic acid in prostate cancer cells. J Proteomics. 2021;246: 104311.34214676 10.1016/j.jprot.2021.104311
89. Monteleone F Taverna S Alessandro R Fontana S SWATH-MS based quantitative proteomics analysis reveals that curcumin alters the metabolic enzyme profile of CML cells by affecting the activity of miR-22/IPO7/HIF-1alpha axis J Exp Clin Cancer Res 2018 37 170 10.1186/s13046-018-0843-y 30045750
Monteleone F, Taverna S, Alessandro R, Fontana S. SWATH-MS based quantitative proteomics analysis reveals that curcumin alters the metabolic enzyme profile of CML cells by affecting the activity of miR-22/IPO7/HIF-1alpha axis. J Exp Clin Cancer Res. 2018;37:170.30045750 10.1186/s13046-018-0843-y
90. Li QW Zhang GL Hao CX Ma YF Sun X Zhang Y SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer J Ethnopharmacol 2021 266 113430 10.1016/j.jep.2020.113430 33011366
Li QW, Zhang GL, Hao CX, Ma YF, Sun X, Zhang Y, et al. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer. J Ethnopharmacol. 2021;266: 113430.33011366 10.1016/j.jep.2020.113430
91. Li L Jing L Wang J Xu W Gong X Zhao Y Autophagic flux is essential for the downregulation of D-dopachrome tautomerase by atractylenolide I to ameliorate intestinal adenoma formation J Cell Commun Signal 2018 12 689 698 10.1007/s12079-018-0454-6 29368299
Li L, Jing L, Wang J, Xu W, Gong X, Zhao Y, et al. Autophagic flux is essential for the downregulation of D-dopachrome tautomerase by atractylenolide I to ameliorate intestinal adenoma formation. J Cell Commun Signal. 2018;12:689–98.29368299 10.1007/s12079-018-0454-6
92. Li C Niu M Wang R Zhou XW Dong B Qi S The modulatory properties of Si Jun Zi Tang enhancing anticancer of gefitinib by an integrating approach Biomed Pharmacother 2019 111 1132 1140 10.1016/j.biopha.2018.12.026 30841426
Li C, Niu M, Wang R, Zhou XW, Dong B, Qi S, et al. The modulatory properties of Si Jun Zi Tang enhancing anticancer of gefitinib by an integrating approach. Biomed Pharmacother. 2019;111:1132–40.30841426 10.1016/j.biopha.2018.12.026
93. Zhang J Wang N Zheng Y Yang B Wang S Wang X Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway J Adv Res 2023 47 189 207 10.1016/j.jare.2022.06.006 35718080
Zhang J, Wang N, Zheng Y, Yang B, Wang S, Wang X, et al. Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway. J Adv Res. 2023;47:189–207.35718080 10.1016/j.jare.2022.06.006
94. Liu H Cao B Li C Han L Xu H Lin J Comparative and mechanistic study of pharmacodynamic difference in anti-breast cancer activity between water and liquor extracts of Xiaojin Pills J Ethnopharmacol 2022 291 115104 10.1016/j.jep.2022.115104 35218896
Liu H, Cao B, Li C, Han L, Xu H, Lin J, et al. Comparative and mechanistic study of pharmacodynamic difference in anti-breast cancer activity between water and liquor extracts of Xiaojin Pills. J Ethnopharmacol. 2022;291: 115104.35218896 10.1016/j.jep.2022.115104
95. Nie S Zhao Y Qiu X Wang W Yao Y Yi M Metabolomic study on nude mice models of gastric cancer treated with modified Si Jun Zi Tang via HILIC UHPLC-Q-TOF/MS analysis Evid Based Complement Alternat Med 2019 2019 3817879 10.1155/2019/3817879 31341492
Nie S, Zhao Y, Qiu X, Wang W, Yao Y, Yi M, et al. Metabolomic study on nude mice models of gastric cancer treated with modified Si Jun Zi Tang via HILIC UHPLC-Q-TOF/MS analysis. Evid Based Complement Alternat Med. 2019;2019:3817879.31341492 10.1155/2019/3817879
96. Zheng C Han L Wu S A metabolic investigation of anticancer effect of G. glabra root extract on nasopharyngeal carcinoma cell line, C666–1 Mol Biol Rep 2019 46 3857 3864 10.1007/s11033-019-04828-1 31066003
Zheng C, Han L, Wu S. A metabolic investigation of anticancer effect of G. glabra root extract on nasopharyngeal carcinoma cell line, C666–1. Mol Biol Rep. 2019;46:3857–64.31066003 10.1007/s11033-019-04828-1
97. Gao R Miao X Sun C Su S Zhu Y Qian D Frankincense and myrrh and their bioactive compounds ameliorate the multiple myeloma through regulation of metabolome profiling and JAK/STAT signaling pathway based on U266 cells BMC Complement Med Ther 2020 20 96 10.1186/s12906-020-2874-0 32293402
Gao R, Miao X, Sun C, Su S, Zhu Y, Qian D, et al. Frankincense and myrrh and their bioactive compounds ameliorate the multiple myeloma through regulation of metabolome profiling and JAK/STAT signaling pathway based on U266 cells. BMC Complement Med Ther. 2020;20:96.32293402 10.1186/s12906-020-2874-0
98. Wang S Yang X Wang W Zhang Y Li T Zhao L Interpretation of the absorbed constituents and pharmacological effect of Spica Schizonepetae extract on non-small cell lung cancer PLoS ONE 2021 16 e0248700 10.1371/journal.pone.0248700 33730076
Wang S, Yang X, Wang W, Zhang Y, Li T, Zhao L, et al. Interpretation of the absorbed constituents and pharmacological effect of Spica Schizonepetae extract on non-small cell lung cancer. PLoS ONE. 2021;16: e0248700.33730076 10.1371/journal.pone.0248700
99. Liang P Ma Y Yang L Mao L Sun Q Sun C Uncovering the mechanisms of active components from toad venom against hepatocellular carcinoma using untargeted metabolomics Molecules 2022 27 7758 10.3390/molecules27227758 36431859
Liang P, Ma Y, Yang L, Mao L, Sun Q, Sun C, et al. Uncovering the mechanisms of active components from toad venom against hepatocellular carcinoma using untargeted metabolomics. Molecules. 2022;27:7758.36431859 10.3390/molecules27227758
100. Zhang J Hong Y Jiang L Yi X Chen Y Liu L Global metabolomic and lipidomic analysis reveal the synergistic effect of bufalin in combination with cinobufagin against HepG2 cells J Proteome Res 2020 19 873 883 10.1021/acs.jproteome.9b00681 31942794
Zhang J, Hong Y, Jiang L, Yi X, Chen Y, Liu L, et al. Global metabolomic and lipidomic analysis reveal the synergistic effect of bufalin in combination with cinobufagin against HepG2 cells. J Proteome Res. 2020;19:873–83.31942794 10.1021/acs.jproteome.9b00681
101. Sun H Zhang AH Liu SB Qiu S Li XN Zhang TL Cell metabolomics identify regulatory pathways and targets of magnoline against prostate cancer J Chromatogr B Analyt Technol Biomed Life Sci 2018 1102–1103 143 151 10.1016/j.jchromb.2018.10.017 30391728
Sun H, Zhang AH, Liu SB, Qiu S, Li XN, Zhang TL, et al. Cell metabolomics identify regulatory pathways and targets of magnoline against prostate cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1102–1103:143–51.30391728 10.1016/j.jchromb.2018.10.017
102. Cheng WY Wu CY Yu J The role of gut microbiota in cancer treatment: friend or foe? Gut 2020 69 1867 1876 10.1136/gutjnl-2020-321153 32759302
Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut. 2020;69:1867–76.32759302 10.1136/gutjnl-2020-321153
103. Wang Y Zhang X Li J Zhang Y Guo Y Chang Q Sini decoction ameliorates colorectal cancer and modulates the composition of gut microbiota in mice Front Pharmacol 2021 12 609992 10.3389/fphar.2021.609992 33776762
Wang Y, Zhang X, Li J, Zhang Y, Guo Y, Chang Q, et al. Sini decoction ameliorates colorectal cancer and modulates the composition of gut microbiota in mice. Front Pharmacol. 2021;12: 609992.33776762 10.3389/fphar.2021.609992
104. Sui H Zhang L Gu K Chai N Ji Q Zhou L YYFZBJS ameliorates colorectal cancer progression in Apc(Min/+) mice by remodeling gut microbiota and inhibiting regulatory T-cell generation Cell Commun Signal 2020 18 113 10.1186/s12964-020-00596-9 32677955
Sui H, Zhang L, Gu K, Chai N, Ji Q, Zhou L, et al. YYFZBJS ameliorates colorectal cancer progression in Apc(Min/+) mice by remodeling gut microbiota and inhibiting regulatory T-cell generation. Cell Commun Signal. 2020;18:113.32677955 10.1186/s12964-020-00596-9
105. Qiu W Sang T Chen H Zhou H Wang Z Zhou H Wenzi Jiedu Recipe ameliorates colorectal cancer by remodeling the gut microbiota and tumor microenvironment Front Oncol 2022 12 915498 10.3389/fonc.2022.915498 36212428
Qiu W, Sang T, Chen H, Zhou H, Wang Z, Zhou H. Wenzi Jiedu Recipe ameliorates colorectal cancer by remodeling the gut microbiota and tumor microenvironment. Front Oncol. 2022;12: 915498.36212428 10.3389/fonc.2022.915498
106. Li Z Zhao Y Cheng J Xu L Wen X Sun Y Integrated plasma metabolomics and gut microbiota analysis: the intervention effect of Jiawei Xiaoyao San on liver depression and spleen deficiency liver cancer rats Front Pharmacol 2022 13 906256 10.3389/fphar.2022.906256 35924041
Li Z, Zhao Y, Cheng J, Xu L, Wen X, Sun Y, et al. Integrated plasma metabolomics and gut microbiota analysis: the intervention effect of Jiawei Xiaoyao San on liver depression and spleen deficiency liver cancer rats. Front Pharmacol. 2022;13: 906256.35924041 10.3389/fphar.2022.906256
107. Lv J Jia Y Li J Kuai W Li Y Guo F Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment Cell Death Dis 2019 10 415 10.1038/s41419-019-1638-6 31138779
Lv J, Jia Y, Li J, Kuai W, Li Y, Guo F, et al. Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment. Cell Death Dis. 2019;10:415.31138779 10.1038/s41419-019-1638-6
108. Farhana L Sarkar S Nangia-Makker P Yu Y Khosla P Levi E Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice PLoS ONE 2020 15 e0229823 10.1371/journal.pone.0229823 32196510
Farhana L, Sarkar S, Nangia-Makker P, Yu Y, Khosla P, Levi E, et al. Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice. PLoS ONE. 2020;15: e0229823.32196510 10.1371/journal.pone.0229823
109. Zhang X Zhao S Song X Jia J Zhang Z Zhou H Inhibition effect of glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition J Pharmacol Sci 2018 137 324 332 10.1016/j.jphs.2018.03.006 30150145
Zhang X, Zhao S, Song X, Jia J, Zhang Z, Zhou H, et al. Inhibition effect of glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition. J Pharmacol Sci. 2018;137:324–32.30150145 10.1016/j.jphs.2018.03.006
110. Hou Z Song F Xing J Zheng Z Liu S Liu Z Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer J Ethnopharmacol 2022 292 115222 10.1016/j.jep.2022.115222 35341933
Hou Z, Song F, Xing J, Zheng Z, Liu S, Liu Z. Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer. J Ethnopharmacol. 2022;292: 115222.35341933 10.1016/j.jep.2022.115222
111. Gu J Sun R Wang Q Liu F Tang D Chang X Standardized Astragalus Mongholicus Bunge-Curcuma aromatica salisb extract efficiently suppresses colon cancer progression through gut microbiota modification in CT26-bearing mice Front Pharmacol 2021 12 714322 10.3389/fphar.2021.714322 34531745
Gu J, Sun R, Wang Q, Liu F, Tang D, Chang X. Standardized Astragalus Mongholicus Bunge-Curcuma aromatica salisb extract efficiently suppresses colon cancer progression through gut microbiota modification in CT26-bearing mice. Front Pharmacol. 2021;12: 714322.34531745 10.3389/fphar.2021.714322
112. Han B Zhai Y Li X Zhao H Sun C Zeng Y Total flavonoids of Tetrastigma hemsleyanum Diels et Gilg inhibits colorectal tumor growth by modulating gut microbiota and metabolites Food Chem 2023 410 135361 10.1016/j.foodchem.2022.135361 36610085
Han B, Zhai Y, Li X, Zhao H, Sun C, Zeng Y, et al. Total flavonoids of Tetrastigma hemsleyanum Diels et Gilg inhibits colorectal tumor growth by modulating gut microbiota and metabolites. Food Chem. 2023;410: 135361.36610085 10.1016/j.foodchem.2022.135361
113. Ren Z Chen X Hong L Zhao X Cui G Li A Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis Small 2020 16 e1905233 10.1002/smll.201905233 31814271
Ren Z, Chen X, Hong L, Zhao X, Cui G, Li A, et al. Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis. Small. 2020;16: e1905233.31814271 10.1002/smll.201905233
114. Huang J Liu D Wang Y Liu L Li J Yuan J Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy Gut 2022 71 734 745 10.1136/gutjnl-2020-321031 34006584
Huang J, Liu D, Wang Y, Liu L, Li J, Yuan J, et al. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy. Gut. 2022;71:734–45.34006584 10.1136/gutjnl-2020-321031
115. Liu SQ Gao ZJ Wu J Zheng HM Li B Sun S Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer J Hematol Oncol 2022 15 19 10.1186/s13045-022-01236-0 35241110
Liu SQ, Gao ZJ, Wu J, Zheng HM, Li B, Sun S, et al. Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer. J Hematol Oncol. 2022;15:19.35241110 10.1186/s13045-022-01236-0
116. Lu Y Yang A Quan C Pan Y Zhang H Li Y A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma Nat Commun 2022 13 4594 10.1038/s41467-022-32283-3 35933472
Lu Y, Yang A, Quan C, Pan Y, Zhang H, Li Y, et al. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nat Commun. 2022;13:4594.35933472 10.1038/s41467-022-32283-3
117. Mehta AK Cheney EM Hartl CA Pantelidou C Oliwa M Castrillon JA Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer Nat Cancer 2021 2 66 82 10.1038/s43018-020-00148-7 33738458
Mehta AK, Cheney EM, Hartl CA, Pantelidou C, Oliwa M, Castrillon JA, et al. Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer. Nat Cancer. 2021;2:66–82.33738458 10.1038/s43018-020-00148-7
118. Liu X Bai M Li H Ye P Duan X Wu C Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer Front Immunol 2022 13 965342 10.3389/fimmu.2022.965342 36389835
Liu X, Bai M, Li H, Ye P, Duan X, Wu C, et al. Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer. Front Immunol. 2022;13: 965342.36389835 10.3389/fimmu.2022.965342
119. Wang L Wang C Tao Z Zhao L Zhu Z Wu W Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer J Exp Clin Cancer Res 2019 38 460 10.1186/s13046-019-1424-4 31703744
Wang L, Wang C, Tao Z, Zhao L, Zhu Z, Wu W, et al. Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer. J Exp Clin Cancer Res. 2019;38:460.31703744 10.1186/s13046-019-1424-4
120. Zhang X Chen H Huang X Xu H Li Y Yuan H Single-cell transcriptomics profiling the compatibility mechanism of As(2)O(3)-indigo naturalis formula based on bone marrow stroma cells Biomed Pharmacother 2022 151 113182 10.1016/j.biopha.2022.113182 35643069
Zhang X, Chen H, Huang X, Xu H, Li Y, Yuan H, et al. Single-cell transcriptomics profiling the compatibility mechanism of As(2)O(3)-indigo naturalis formula based on bone marrow stroma cells. Biomed Pharmacother. 2022;151: 113182.35643069 10.1016/j.biopha.2022.113182
121. Liang MK Liang XQ Zhong J Wei YT Lian ZP Huang ZK Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer J Ethnopharmacol 2021 270 113787 10.1016/j.jep.2021.113787 33422657
Liang MK, Liang XQ, Zhong J, Wei YT, Lian ZP, Huang ZK, et al. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer. J Ethnopharmacol. 2021;270: 113787.33422657 10.1016/j.jep.2021.113787
122. Wan X Tou F Zeng J Chen X Li S Chen L Integrative analysis and identification of key elements and pathways regulated by Traditional Chinese Medicine (Yiqi Sanjie formula) in colorectal cancer Front Pharmacol 2022 13 1090599 10.3389/fphar.2022.1090599 36582529
Wan X, Tou F, Zeng J, Chen X, Li S, Chen L, et al. Integrative analysis and identification of key elements and pathways regulated by Traditional Chinese Medicine (Yiqi Sanjie formula) in colorectal cancer. Front Pharmacol. 2022;13:1090599.36582529 10.3389/fphar.2022.1090599
123. Yu CT Chen T Lu S Hu W Zhang Q Tan J Identification of significant modules and targets of Xian-Lian-Jie-Du decoction based on the analysis of transcriptomics, proteomics and single-cell transcriptomics in colorectal tumor J Inflamm Res 2022 15 1483 1499 10.2147/JIR.S344861 35256851
Yu CT, Chen T, Lu S, Hu W, Zhang Q, Tan J, et al. Identification of significant modules and targets of Xian-Lian-Jie-Du decoction based on the analysis of transcriptomics, proteomics and single-cell transcriptomics in colorectal tumor. J Inflamm Res. 2022;15:1483–99.35256851 10.2147/JIR.S344861
124. Guo C Liu X Xu Y Han X Xie R Meng X Exploring the mechanism of action of canmei formula against colorectal adenoma through multi-omics technique Front Cell Dev Biol 2021 9 778826 10.3389/fcell.2021.778826 34926462
Guo C, Liu X, Xu Y, Han X, Xie R, Meng X, et al. Exploring the mechanism of action of canmei formula against colorectal adenoma through multi-omics technique. Front Cell Dev Biol. 2021;9: 778826.34926462 10.3389/fcell.2021.778826
125. Li S Pei W Yuan W Yu D Song H Zhang H Multi-omics joint analysis reveals the mechanism of action of the traditional Chinese medicine Marsdenia tenacissima (Roxb) Moon in the treatment of hepatocellular carcinoma J Ethnopharmacol 2022 293 115285 10.1016/j.jep.2022.115285 35429621
Li S, Pei W, Yuan W, Yu D, Song H, Zhang H. Multi-omics joint analysis reveals the mechanism of action of the traditional Chinese medicine Marsdenia tenacissima (Roxb) Moon in the treatment of hepatocellular carcinoma. J Ethnopharmacol. 2022;293: 115285.35429621 10.1016/j.jep.2022.115285
126. Li Z Bao H Deciphering key regulators of Inonotus hispidus petroleum ether extract involved in anti-tumor through whole transcriptome and proteome analysis in H22 tumor-bearing mice model J Ethnopharmacol 2022 296 115468 10.1016/j.jep.2022.115468 35718054
Li Z, Bao H. Deciphering key regulators of Inonotus hispidus petroleum ether extract involved in anti-tumor through whole transcriptome and proteome analysis in H22 tumor-bearing mice model. J Ethnopharmacol. 2022;296: 115468.35718054 10.1016/j.jep.2022.115468
127. Wiench B Chen YR Paulsen M Hamm R Schroder S Yang NS Integration of Different “-omics” technologies identifies inhibition of the igf1r-akt-mtor signaling cascade involved in the cytotoxic effect of shikonin against leukemia cells Evid Based Complement Alternat Med 2013 2013 818709 10.1155/2013/818709 23861714
Wiench B, Chen YR, Paulsen M, Hamm R, Schroder S, Yang NS, et al. Integration of Different “-omics” technologies identifies inhibition of the igf1r-akt-mtor signaling cascade involved in the cytotoxic effect of shikonin against leukemia cells. Evid Based Complement Alternat Med. 2013;2013: 818709.23861714 10.1155/2013/818709
128. Feng F Pan L Wu J Li L Xu H Yang L Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo Int J Biol Sci 2021 17 4340 4352 10.7150/ijbs.64675 34803502
Feng F, Pan L, Wu J, Li L, Xu H, Yang L, et al. Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo. Int J Biol Sci. 2021;17:4340–52.34803502 10.7150/ijbs.64675
129. Yang A Wu Q Wang A Chen Q Yang J Tao Y Integrated transcriptomics and metabolomics analyses to investigate the anticancer mechanisms of cinobufagin against liver cancer through interfering with lipid, amino acid, carbohydrate, and nucleotide metabolism Bioorg Chem 2023 130 106229 10.1016/j.bioorg.2022.106229 36335648
Yang A, Wu Q, Wang A, Chen Q, Yang J, Tao Y, et al. Integrated transcriptomics and metabolomics analyses to investigate the anticancer mechanisms of cinobufagin against liver cancer through interfering with lipid, amino acid, carbohydrate, and nucleotide metabolism. Bioorg Chem. 2023;130: 106229.36335648 10.1016/j.bioorg.2022.106229
130. Huang CJ Zhang CY Zhao YK Wang D Zhuang L Qian L Bufalin inhibits tumorigenesis and SREBP-1-mediated lipogenesis in hepatocellular carcinoma via modulating the ATP1A1/CA2 axis Am J Chin Med 2023 51 461 485 10.1142/S0192415X23500246 36655687
Huang CJ, Zhang CY, Zhao YK, Wang D, Zhuang L, Qian L, et al. Bufalin inhibits tumorigenesis and SREBP-1-mediated lipogenesis in hepatocellular carcinoma via modulating the ATP1A1/CA2 axis. Am J Chin Med. 2023;51:461–85.36655687 10.1142/S0192415X23500246
131. Hsin KY Matsuoka Y Asai Y Kamiyoshi K Watanabe T Kawaoka Y systemsDock: a web server for network pharmacology-based prediction and analysis Nucleic Acids Res 2016 44 W507 W513 10.1093/nar/gkw335 27131384
Hsin KY, Matsuoka Y, Asai Y, Kamiyoshi K, Watanabe T, Kawaoka Y, et al. systemsDock: a web server for network pharmacology-based prediction and analysis. Nucleic Acids Res. 2016;44:W507–13.27131384 10.1093/nar/gkw335
132. Wang Y Yang H Chen L Jafari M Tang J Network-based modeling of herb combinations in traditional Chinese medicine Brief Bioinform 2021 22 bbab106 10.1093/bib/bbab106 33834186
Wang Y, Yang H, Chen L, Jafari M, Tang J. Network-based modeling of herb combinations in traditional Chinese medicine. Brief Bioinform. 2021;22:bbab106.33834186 10.1093/bib/bbab106
133. Tan HY Ho VW Chan YT Zhang C Wang N Xia W Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: a transcriptomics/ bio-informatics biological validation approach Pharmacol Res 2020 155 104415 10.1016/j.phrs.2019.104415 31465829
Tan HY, Ho VW, Chan YT, Zhang C, Wang N, Xia W, et al. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: a transcriptomics/ bio-informatics biological validation approach. Pharmacol Res. 2020;155: 104415.31465829 10.1016/j.phrs.2019.104415
134. Luo Q Huang S Zhao L Liu J Ma Q Wang Y Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-kappaB/STAT3 pathway in mice as revealed by network pharmacology study Front Pharmacol 2022 13 893231 10.3389/fphar.2022.893231 35991881
Luo Q, Huang S, Zhao L, Liu J, Ma Q, Wang Y, et al. Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-kappaB/STAT3 pathway in mice as revealed by network pharmacology study. Front Pharmacol. 2022;13: 893231.35991881 10.3389/fphar.2022.893231
135. Xu X Zhang J Zhang Z Wang M Liu Y Li X Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer Bioengineered 2020 11 1170 1188 10.1080/21655979.2020.1834726 33092442
Xu X, Zhang J, Zhang Z, Wang M, Liu Y, Li X. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer. Bioengineered. 2020;11:1170–88.33092442 10.1080/21655979.2020.1834726
136. Li JX Li RZ Sun A Zhou H Neher E Yang JS Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling Pharmacol Res 2021 171 105574 10.1016/j.phrs.2021.105574 34419228
Li JX, Li RZ, Sun A, Zhou H, Neher E, Yang JS, et al. Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling. Pharmacol Res. 2021;171: 105574.34419228 10.1016/j.phrs.2021.105574
137. Li Q Chen JX Wu Y Lv LL Ying HF Zhu WH The mechanism of FZXJJZ decoction suppresses colorectal liver metastasis via the VDR/TGF-beta/Snail1 signaling pathways based on network pharmacology-TCGA data-transcriptomics analysis J Ethnopharmacol 2022 287 114904 10.1016/j.jep.2021.114904 34952191
Li Q, Chen JX, Wu Y, Lv LL, Ying HF, Zhu WH, et al. The mechanism of FZXJJZ decoction suppresses colorectal liver metastasis via the VDR/TGF-beta/Snail1 signaling pathways based on network pharmacology-TCGA data-transcriptomics analysis. J Ethnopharmacol. 2022;287: 114904.34952191 10.1016/j.jep.2021.114904
138. Gao F Niu Y Sun L Li W Xia H Zhang Y Integrating network pharmacology and transcriptomic validation to investigate the efficacy and mechanism of Mufangji decoction preventing lung cancer J Ethnopharmacol 2022 298 115573 10.1016/j.jep.2022.115573 35917893
Gao F, Niu Y, Sun L, Li W, Xia H, Zhang Y, et al. Integrating network pharmacology and transcriptomic validation to investigate the efficacy and mechanism of Mufangji decoction preventing lung cancer. J Ethnopharmacol. 2022;298: 115573.35917893 10.1016/j.jep.2022.115573
139. Yang MD Zhou WJ Chen XL Chen J Ji Q Li Q Therapeutic effect and mechanism of Bushen-Jianpi-Jiedu decoction combined with chemotherapeutic drugs on postoperative colorectal cancer Front Pharmacol 2021 12 524663 10.3389/fphar.2021.524663 33828479
Yang MD, Zhou WJ, Chen XL, Chen J, Ji Q, Li Q, et al. Therapeutic effect and mechanism of Bushen-Jianpi-Jiedu decoction combined with chemotherapeutic drugs on postoperative colorectal cancer. Front Pharmacol. 2021;12: 524663.33828479 10.3389/fphar.2021.524663
140. Zhu LM Shi HX Sugimoto M Bandow K Sakagami H Amano S Feiyanning formula induces apoptosis of lung adenocarcinoma cells by activating the mitochondrial pathway Front Oncol 2021 11 690878 10.3389/fonc.2021.690878 34277435
Zhu LM, Shi HX, Sugimoto M, Bandow K, Sakagami H, Amano S, et al. Feiyanning formula induces apoptosis of lung adenocarcinoma cells by activating the mitochondrial pathway. Front Oncol. 2021;11: 690878.34277435 10.3389/fonc.2021.690878
141. Qian X Bi QY Wang ZN Han F Liu LM Song LB Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro J Ethnopharmacol 2023 307 116198 10.1016/j.jep.2023.116198 36690307
Qian X, Bi QY, Wang ZN, Han F, Liu LM, Song LB, et al. Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro. J Ethnopharmacol. 2023;307: 116198.36690307 10.1016/j.jep.2023.116198
142. Li Y Gong Y Zhang X Wang J Cheng Y Liu F Exploring the synergistic mechanism of Gegen Qinlian Decoction on the Wnt signaling pathway using an integrated strategy of network pharmacology and RNA-seq J Ethnopharmacol 2021 278 114283 10.1016/j.jep.2021.114283 34098017
Li Y, Gong Y, Zhang X, Wang J, Cheng Y, Liu F, et al. Exploring the synergistic mechanism of Gegen Qinlian Decoction on the Wnt signaling pathway using an integrated strategy of network pharmacology and RNA-seq. J Ethnopharmacol. 2021;278: 114283.34098017 10.1016/j.jep.2021.114283
143. Zhuang Z Huang D Sheng ZR Ye ZJ Jiang H Yuan Y Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer Phytomedicine 2023 108 154491 10.1016/j.phymed.2022.154491 36368285
Zhuang Z, Huang D, Sheng ZR, Ye ZJ, Jiang H, Yuan Y, et al. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer. Phytomedicine. 2023;108: 154491.36368285 10.1016/j.phymed.2022.154491
144. Liu Z Ma H Lai Z Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology BMC Complement Med Ther 2021 21 263 10.1186/s12906-021-03425-9 34663301
Liu Z, Ma H, Lai Z. Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology. BMC Complement Med Ther. 2021;21:263.34663301 10.1186/s12906-021-03425-9
145. Wang G Wang YZ Yu Y Wang JJ Yin PH Xu K Triterpenoids extracted from Rhus chinensis Mill act against colorectal cancer by inhibiting enzymes in glycolysis and glutaminolysis: network analysis and experimental validation Nutr Cancer 2020 72 293 319 10.1080/01635581.2019.1631858 31267795
Wang G, Wang YZ, Yu Y, Wang JJ, Yin PH, Xu K. Triterpenoids extracted from Rhus chinensis Mill act against colorectal cancer by inhibiting enzymes in glycolysis and glutaminolysis: network analysis and experimental validation. Nutr Cancer. 2020;72:293–319.31267795 10.1080/01635581.2019.1631858
146. Liu Z Sun Y Zhen H Nie C Network Pharmacology Integrated with Transcriptomics Deciphered the Potential Mechanism of Codonopsis pilosula against Hepatocellular Carcinoma Evid Based Complement Alternat Med 2022 2022 1340194 35388300
Liu Z, Sun Y, Zhen H, Nie C. Network Pharmacology Integrated with Transcriptomics Deciphered the Potential Mechanism of Codonopsis pilosula against Hepatocellular Carcinoma. Evid Based Complement Alternat Med. 2022;2022:1340194.35388300
147. Feng X Shi H Chao X Zhao F Song L Wei M Deciphering the Pharmacological Mechanism of the Herb Radix Ophiopogonis in the Treatment of Nasopharyngeal Carcinoma by Integrating iTRAQ-Coupled 2-D LC-MS/MS Analysis and Network Investigation Front Pharmacol 2019 10 253 10.3389/fphar.2019.00253 30936832
Feng X, Shi H, Chao X, Zhao F, Song L, Wei M, et al. Deciphering the Pharmacological Mechanism of the Herb Radix Ophiopogonis in the Treatment of Nasopharyngeal Carcinoma by Integrating iTRAQ-Coupled 2-D LC-MS/MS Analysis and Network Investigation. Front Pharmacol. 2019;10:253.30936832 10.3389/fphar.2019.00253
148. Qu J Ke F Liu Z Yang X Li X Xu H Uncovering the mechanisms of dandelion against triple-negative breast cancer using a combined network pharmacology, molecular pharmacology and metabolomics approach Phytomedicine 2022 99 153986 10.1016/j.phymed.2022.153986 35183931
Qu J, Ke F, Liu Z, Yang X, Li X, Xu H, et al. Uncovering the mechanisms of dandelion against triple-negative breast cancer using a combined network pharmacology, molecular pharmacology and metabolomics approach. Phytomedicine. 2022;99: 153986.35183931 10.1016/j.phymed.2022.153986
149. Xiao Y Yu D Tumor microenvironment as a therapeutic target in cancer Pharmacol Ther 2021 221 107753 10.1016/j.pharmthera.2020.107753 33259885
Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221: 107753.33259885 10.1016/j.pharmthera.2020.107753
150. Iida N Dzutsev A Stewart CA Smith L Bouladoux N Weingarten RA Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment Science 2013 342 967 970 10.1126/science.1240527 24264989
Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342:967–70.24264989 10.1126/science.1240527
151. Li X Chu S Lin M Gao Y Liu Y Yang S Anticancer property of ginsenoside Rh2 from ginseng Eur J Med Chem 2020 203 112627 10.1016/j.ejmech.2020.112627 32702586
Li X, Chu S, Lin M, Gao Y, Liu Y, Yang S, et al. Anticancer property of ginsenoside Rh2 from ginseng. Eur J Med Chem. 2020;203: 112627.32702586 10.1016/j.ejmech.2020.112627
152. Han X Wei Q Lv Y Weng L Huang H Wei Q Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment Mol Ther 2022 30 327 340 10.1016/j.ymthe.2021.08.028 34450250
Han X, Wei Q, Lv Y, Weng L, Huang H, Wei Q, et al. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. Mol Ther. 2022;30:327–40.34450250 10.1016/j.ymthe.2021.08.028
153. Zhu X Yao Q Yang P Zhao D Yang R Bai H Multi-omics approaches for in-depth understanding of therapeutic mechanism for Traditional Chinese Medicine Front Pharmacol 2022 13 1031051 10.3389/fphar.2022.1031051 36506559
Zhu X, Yao Q, Yang P, Zhao D, Yang R, Bai H, et al. Multi-omics approaches for in-depth understanding of therapeutic mechanism for Traditional Chinese Medicine. Front Pharmacol. 2022;13:1031051.36506559 10.3389/fphar.2022.1031051
154. Liberti MV Locasale JW The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 2016 41 211 218 10.1016/j.tibs.2015.12.001 26778478
Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41:211–8.26778478 10.1016/j.tibs.2015.12.001
155. Menendez JA Lupu R Fatty acid synthase (FASN) as a therapeutic target in breast cancer Expert Opin Ther Targets 2017 21 1001 1016 10.1080/14728222.2017.1381087 28922023
Menendez JA, Lupu R. Fatty acid synthase (FASN) as a therapeutic target in breast cancer. Expert Opin Ther Targets. 2017;21:1001–16.28922023 10.1080/14728222.2017.1381087
156. Menendez JA Lupu R Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat Rev Cancer 2007 7 763 777 10.1038/nrc2222 17882277
Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763–77.17882277 10.1038/nrc2222
